TW201315380A - Formulations for paddy rice fields - Google Patents

Formulations for paddy rice fields Download PDF

Info

Publication number
TW201315380A
TW201315380A TW101130035A TW101130035A TW201315380A TW 201315380 A TW201315380 A TW 201315380A TW 101130035 A TW101130035 A TW 101130035A TW 101130035 A TW101130035 A TW 101130035A TW 201315380 A TW201315380 A TW 201315380A
Authority
TW
Taiwan
Prior art keywords
formulation
encapsulated
microcapsule
insecticide
capsule
Prior art date
Application number
TW101130035A
Other languages
Chinese (zh)
Inventor
Christian Sowa
Gerhard Peter Dohmen
Martin Obermann
Nadine Riediger
Kristina Klappach
Manuel Schmitt
Reinhard Stierl
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of TW201315380A publication Critical patent/TW201315380A/en

Links

Abstract

The present invention relates to microcapsules, formulations comprising such microcapsules and to methods of combating phytopathogenic pests in paddy rice fields based on such microcapsules.

Description

用於稻田之調配物 Formulated for rice fields

本發明係關於一種微膠囊、包括該等微膠囊之調配物及基於該等微膠囊防治稻田中之植物致病害蟲之方法,其中(i)膠囊具有核心-外殼結構;且(ii)至少80%之殺蟲劑在25℃下於核心中溶於有機溶劑中;且(iii)膠囊外殼係基於包括呈聚合形式之多官能異氰酸酯及多胺之聚胺基甲酸酯;且(iv)膠囊外殼重量相對於膠囊重量之比率為1-20重量%。 The present invention relates to a microcapsule, a formulation comprising the microcapsules, and a method for controlling phytopathogenic pests in rice fields based on the microcapsules, wherein (i) the capsule has a core-shell structure; and (ii) at least 80 % of the pesticide is dissolved in the organic solvent in the core at 25 ° C; and (iii) the capsule shell is based on a polyurethane comprising a polyfunctional isocyanate and a polyamine in a polymerized form; and (iv) a capsule The ratio of the weight of the outer shell to the weight of the capsule is from 1 to 20% by weight.

稻穀殺蟲處理中之一主要目標係達成所施加調配物之殺蟲劑之靶向釋放同時使其快速黏著至各別植物,從而避免殺蟲劑至環境中之不期望釋放。後者可構成重大問題,此乃因一方面具有環境安全問題且失去關於殺蟲劑抵抗土壤傳播之真菌及昆蟲之保護,從而導致業內迫切需要提供滿足該等目標之專用調配物。 One of the primary targets of rice insecticidal treatment is to achieve targeted release of the pesticide of the applied formulation while allowing it to adhere quickly to individual plants, thereby avoiding undesired release of the pesticide into the environment. The latter can pose a major problem because of the environmental safety issues on the one hand and the loss of protection against insecticides and insects that are resistant to soil transmission, leading to an urgent need in the industry to provide specialized formulations that meet these objectives.

因此,本發明目標係提供用於處理稻田之調配物,其提供殺蟲劑在擬保護植物上之快速活性,藉此防止顯著釋放至環境(水或土壤)中。 Accordingly, it is an object of the present invention to provide formulations for treating rice fields that provide rapid activity of the pesticide on the plants to be protected, thereby preventing significant release into the environment (water or soil).

此在以下事實中尤其重要:若超過殺蟲劑物質在水中之某些濃度,則許多殺蟲劑可對於水生有機體具有不期望副作用。因此,在殺蟲劑接觸植物且各別害蟲(例如有害真菌、有害昆蟲)需要確立足夠濃度以使得能夠有效控制害 蟲時,同時減小殺蟲劑在水中之並行釋放將具有重大環境益處。 This is especially important in the fact that many pesticides can have undesirable side effects on aquatic organisms if certain concentrations of pesticide material in water are exceeded. Therefore, when the insecticide contacts the plant and the individual pests (such as harmful fungi, harmful insects) need to establish sufficient concentration to enable effective control At the same time, reducing the parallel release of the pesticide in the water will have significant environmental benefits.

本發明之另一潛在目標係期望獲得改良植物之調配物,此改良過程通常且在下文中稱為「植物健康」,其特定而言係關於稻米植物。 Another potential object of the present invention is to obtain a formulation of an improved plant, which is generally and hereinafter referred to as "plant health", in particular with respect to rice plants.

術語植物健康包括對植物實施之與害蟲控制無關的各種改良。舉例而言,可提及之有利性質係包含以下之改良作物特性:出苗、作物產量、蛋白質含量、油含量、澱粉含量、增強根系(改良根生長)、改良逆境耐受力(例如對於乾旱、熱、鹽、UV、水、寒冷之抗性)、減少乙烯(減少產生及/或抑制接受)、分蘖增加、增加植物高度、較大葉片、較少死亡基生葉、強壯分蘖枝、增綠葉色、色素含量、光合成活性、較少所需輸入(例如肥料或水)、需要較少種子、生產力更高之蘖、提早開花、提早穀物成熟、較低植物拔節(倒伏)、增加枝條生長、增強植物活力、增加植物林分及提早及更佳發芽。 The term plant health includes various modifications to plants that are not related to pest control. For example, advantageous properties that may be mentioned include improved crop characteristics: emergence, crop yield, protein content, oil content, starch content, enhanced roots (modified root growth), improved stress tolerance (eg for drought, Heat, salt, UV, water, cold resistance), reduce ethylene (reduce production and / or inhibit acceptance), increase tillering, increase plant height, larger leaves, less dead basal leaves, strong lychee, green color , pigment content, photosynthetic activity, less required input (eg fertilizer or water), less seed required, higher productivity, early flowering, early grain ripening, lower plant jointing (falling), increased shoot growth, enhancement Plant vigor, increase plant stand and early and better germination.

藉由提供微膠囊來解決該目標,其中(i)膠囊具有核心-外殼結構;且(ii)至少80%之殺蟲劑在25℃下於核心中溶於有機溶劑中;且(iii)膠囊外殼係基於包括呈聚合形式之多官能異氰酸酯及多胺之聚胺基甲酸酯;且(iv)膠囊外殼重量相對於膠囊重量之比率為1-20重量%。 This object is solved by providing microcapsules, wherein (i) the capsule has a core-shell structure; and (ii) at least 80% of the pesticide is dissolved in the organic solvent in the core at 25 ° C; and (iii) the capsule The outer shell is based on a polyurethane comprising a polyfunctional isocyanate and a polyamine in a polymerized form; and (iv) the ratio of the weight of the capsule shell to the weight of the capsule is from 1 to 20% by weight.

較佳地,殺蟲劑重量相對於膠囊總重量之比率為5-50重量%、較佳地8-45 wt%、更佳地25-35重量%。 Preferably, the ratio of the weight of the insecticide to the total weight of the capsule is from 5 to 50% by weight, preferably from 8 to 45% by weight, more preferably from 25 to 35% by weight.

如上所述,核心中之至少80 wt%、較佳地至少90 wt%之殺蟲劑在25℃下溶於有機溶劑中。 As mentioned above, at least 80% by weight, preferably at least 90% by weight of the pesticide in the core is soluble in the organic solvent at 25 °C.

術語「殺蟲劑」係指至少一種選自殺真菌劑及殺昆蟲劑之群之殺蟲劑。亦可使用來自上述種類中之兩種或多種殺蟲劑之混合物。專家熟知該等殺蟲劑,較其他出版物,該等殺蟲劑尤其可參見Pesticide Manual,第14版(2006),The British Crop Protection Council,London或e-Pesticide Manual V5.1,ISBN 978 1 901396 84 3。 The term "insecticide" means at least one insecticide selected from the group of fungicides and insecticides. Mixtures of two or more insecticides from the above categories may also be used. Experts are familiar with such insecticides, and other insecticides are described in particular in the Pesticide Manual, 14th Edition (2006), The British Crop Protection Council, London or e-Pesticide Manual V5.1, ISBN 978 1 901396 84 3.

適宜殺真菌劑為:A)呼吸抑制劑- 在Qo位點處之複合物III之抑制劑:嗜毬果傘素(strobilurines),亞托敏(azoxystrobin)、甲香菌酯(coumethoxystrobin)、丁香菌酯(coumoxystrobin)、醚菌胺(dimoxystrobin)、烯肟菌酯(enestroburin)、芬那敏史卓賓(fenaminstrobin)、芬咢史卓賓(fenoxystrobin)/氟菌蟎酯(flufenoxystrobin)、氟嘧菌酯(fluoxastrobin)、克收欣(kresoxim-methy)、苯氧菌胺(metominostrobin)、肟醚菌胺(orysastrobin)、吡啶氧菌酯(picoxystrobin)、百克敏(百克敏)、吡唑胺菌酯(pyrametostrobin)、唑菌酯(pyraoxystrobin)、三氟敏(trifloxystrobin)、2-[2-(2,5-二甲基-苯氧基甲基)-苯基]-3-甲氧基-丙烯酸甲酯及2-(2- (3-(2,6-二氯苯基)-1-甲基-亞烯丙基胺基氧基甲基)-苯基)-2-甲氧基亞胺基-N-甲基-乙醯胺;及吡菌苯威(pyribencarb)、氯啶菌酯(triclopyricarb/chlorodincarb)、凡殺同(famoxadone)、咪唑菌酮(fenamidone);- Qi位點處之複合物III之抑制劑:賽座滅(cyazofamid)、氟硫滅(amisulbrom)、2-甲基丙酸[(3S,6S,7R,8R)-8-苄基-3-[(3-乙醯氧基-4-甲氧基-吡啶-2-羰基-胺基]-6-甲基-4,9-二側氧基-1,5-二氧雜環壬烷-7-基]酯、2-甲基丙酸[(3S,6S,7R,8R)-8-苄基-3-[[3-(乙醯氧基甲氧基)-4-甲氧基-吡啶-2-羰基]胺基]-6-甲基-4,9-二側氧基-1,5-二氧雜環壬烷-7-基]酯、2-甲基丙酸[(3S,6S,7R,8R)-8-苄基-3-[(3-異丁氧基羰基氧基-4-甲氧基-吡啶-2-羰基-胺基]-6-甲基-4,9-二側氧基-1,5-二氧雜環壬烷-7-基]酯、2-甲基丙酸[(3S,6S,7R,8R)-8-苄基-3-[[3-(1,3-苯并間二氧環戊烯-5-基甲氧基)-4-甲氧基-吡啶-2-羰基]胺基]-6-甲基-4,9-二側氧基-1,5-二氧雜環壬烷-7-基]酯;- 複合物II之抑制劑(例如甲醯胺類):麥鏽靈(benodanil)、必殺酚(bixafen)、白克列(boscalid)、萎鏽靈(carboxin)、甲呋醯胺(fenfuram)、氟吡菌醯胺(fluopyram)、福多寧(flutolanil)、氟殺比得(fluxapyroxad)、福拉比(furametpyr)、異吡唑醯胺(isopyrazam)、滅普寧(mepronil)、嘉保信(oxycarboxin)、噴氟芬(penflufen)、吡噻菌胺(penthiopyrad)、環丙吡菌胺(sedaxane)、克枯爛 (tecloftalam)、賽氟滅(thifluzamide)、N-(4'-三氟甲基硫代聯苯-2-基)-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(2-(1,3,3-三甲基-丁基)-苯基)-1,3-二甲基-5-氟-1H-吡唑-4-甲醯胺、N-[9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲醇萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺;- 其他呼吸抑制劑(例如複合物I,解偶聯劑):二氟林(diflumetorim)、(5,8-二氟喹唑啉-4-基)-{2-[2-氟-4-(4-三氟甲基吡啶-2-基氧基)-苯基]-乙基}-胺;硝基苯基衍生物:百蟎克(binapacryl)、大脫蟎(dinobuton)、白粉克(dinocap)、扶吉胺(fluazinam);富米綜(ferimzone);有機金屬化合物:辛唑嘧菌胺(ametoctradin);及矽噻菌胺(silthiofam);B)類固醇生物合成抑制劑(SBI殺真菌劑)- C14去甲基酶抑制劑(DMI殺真菌劑):三唑:氧環唑(azaconazole)、比多農(bitertanol)、溴克座(bromuconazole)、環克座(cyproconazole)、待克利(difenoconazole)、達克利(diniconazole)、達克利-M(diniconazole-M)、依普座(epoxiconazole)、芬克座(fenbuconazole)、氟喹唑(fluquinconazole)、護矽得(flusilazole)、護汰芬(flutriafol)、菲克利(hexaconazole)、易胺座(imibenconazole)、種菌唑(ipconazole)、滅特座(metconazole)、邁克尼(myclobutanil)、氰霜唑(oxpoconazole)、巴克素(paclobutrazole)、平克座(penconazole)、普克利 (propiconazole)、丙硫菌唑(prothioconazole)、矽氟唑(simeconazole)、得克利(tebuconazole)、四克利(tetraconazole)、三泰芬(triadimefon)、三泰隆(triadimenol)、滅菌唑(triticonazole)、烯效唑(uniconazole);咪唑:依滅列(imazalil)、披扶座(pefurazoate)、撲克拉(prochloraz)、賽福座(triflumizol);嘧啶、吡啶及六氫吡嗪:芬瑞莫(fenarimol)、尼瑞莫(nuarimol)、比芬諾(pyrifenox)、賽福寧(triforine);- δ14-還原酶抑制劑:阿迪莫夫(aldimorph)、十二環嗎啉(dodemorph)、十二環嗎啉乙酸鹽(dodemorph-acetate)、芬普福(fenpropimorph)、三得芬(tridemorph)、苯鏽啶(fenpropidin)、粉病靈(piperalin)、螺環菌胺(spiroxamine);- 3-酮還原酶之抑制劑:環醯菌胺(fenhexamid);C)核酸合成抑制劑- 苯基醯胺或醯基胺基酸殺真菌劑:本達樂(benalaxyl)、本達樂-M(benalaxyl-M)、精苯霜靈(kiralaxyl)、滅達樂(metalaxyl)、滅達樂-M(metalaxyl-M)(右滅達樂(mefenoxam))、甲呋醯胺(ofurace)、歐殺斯(oxadixyl);- 其他:殺紋寧(hymexazole)、辛噻酮(octhilinone)、歐索林酸(oxolinic acid)、布瑞莫(bupirimate)、5-氟胞嘧啶、5-氟-2-(對甲苯基甲氧基)嘧啶-4-胺、5-氟-2-(4-氟苯基甲氧基)嘧啶-4-胺; D)細胞分裂及細胞骨架之抑制劑- 微管蛋白抑制劑,例如苯并咪唑、多保淨(thiophanate):免賴得(benomyl)、貝芬替(carbendazim)、麥穗寧(fuberidazole)、腐絕(thiabendazole)、甲基多保淨(thiophanate-methyl);三唑并嘧啶:5-氯-7-(4-甲基六氫吡啶-1-基)-6-(2,4,6-三氟苯基)-[1,2,4]三唑并[1,5-a]嘧啶- 其他細胞分裂抑制劑:乙黴威(diethofencarb)、噻唑菌胺(ethaboxam)、賓克隆(pencycuron)、氟吡菌胺(fluopicolide)、座賽胺(zoxamide)、滅芬農(metrafenone)、吡利酚酮(pyriofenone);E)胺基酸及蛋白質合成之抑制劑- 甲硫胺酸合成抑制劑(苯胺基-嘧啶):賽普洛(cyprodinil)、滅派林(mepanipyrim)、嘧黴胺(pyrimethanil);- 蛋白質合成抑制劑:保米黴素(blasticidin-S)、嘉賜黴素(kasugamycin)、嘉賜黴素鹽酸鹽水合物(kasugamycin hydrochloride-hydrate)、米多黴素(mildiomycin)、鏈黴素(streptomycin)、土黴素(oxytetracyclin)、保粒黴素(polyoxine)及維利黴素A(validamycin A);F)信號轉導抑制劑- MAP/組胺酸激酶抑制劑:氟氯菌核利(fluoroimid)、依普同(iprodione)、撲滅寧(procymidone)、免克寧(vinclozolin)、拌種咯(fenpiclonil)、護汰寧(fludioxonil); - G蛋白抑制劑:快諾芬(quinoxyfen);G)脂質及膜合成抑制劑- 磷脂生物合成抑制劑:護粒松(edifenphos)、丙基喜樂松(iprobenfos)、白粉松(pyrazophos)、亞賜圃(isoprothiolane);- 脂質過氧化過氧化抑制劑:大克爛(dicloran)、五氯硝基苯(quintozene)、四氯硝基苯(tecnazene)、脫克松(tolclofos-methyl)、聯苯(biphenyl)、地茂丹殺菌劑(chloroneb)、依得利(etridiazole);- 磷脂生物合成及細胞壁沈積抑制劑:達滅芬(dimethomorph)、氟嗎啉(flumorph)、曼普胺(mandipropamid)、丁吡嗎啉(pyrimorph)、本賽夫利卡(benthiavalicarb)、纈黴威(iprovalicarb)、瓦利本(valifenalate)及N-(1-(1-(4-氰基-苯基)乙烷磺醯基)丁-2-基)胺基甲酸-(4-氟苯基)酯;- 影響細胞膜滲透性及脂肪酸之化合物:普潘莫卡(propamocarb)、普拔克(propamocarb-hydrochlorid)H)具有多位點作用之抑制劑- 無機活性物質:-- 有機氯化合物(例如鄰苯二甲醯亞胺、磺醯胺、氯腈):敵菌靈(anilazine)、益發靈(dichlofluanid)、雙氯酚(dichlorophen)、氟硫滅(flusulfamide)、六氯苯、五氯酚(pentachlorphenole)及其鹽、熱必斯(phthalide)、甲基益 發靈(tolylfluanid)、N-(4-氯-2-硝基-苯基)-N-乙基-4-甲基-苯磺醯胺;- 胍類及其他:胍(guanidine)、多寧(dodine)、雙胍辛胺(guazatine)、雙胍辛胺乙酸鹽(guazatine-acetate)、克熱淨(iminoctadine)、克熱淨三乙酸鹽(iminoctadine-triacetate)、克熱淨-叁(烷苯磺酸鹽)(iminoctadine-tris(albesilate));I)細胞壁合成抑制劑- 葡聚糖合成之抑制劑:維利黴素、保粒黴素B(polyoxin B);黑色素合成抑制劑:百快隆(pyroquilon)、三賽唑(tricyclazole)、加普胺(carpropamid)、雙環維林(dicyclomet)、芬諾尼(fenoxanil);J)植物防禦誘導劑- S-甲基-阿西本唑(acibenzolar-S-methyl)、撲殺熱(probenazole)、異噻菌胺(isotianil)、噻醯菌胺(tiadinil)、調環酸鈣(prohexadione-calcium);膦酸酯:K)未知之作用模式- 蟎離丹(chinomethionat)、賽芬胺(cyflufenamid)、克絕(cymoxanil)、咪菌威(debacarb)、達滅淨(diclomezine)、野燕枯(difenzoquat)、草吡唑(difenzoquat-methylsulfate)、胺苯吡菌酮(fenpyrazamine)、氟滅歐(flumetover)、氟硫滅、氟替寧(flutianil)、磺菌威(methasulfocarb)、氯啶(nitrapyrin)、酞菌酯(nitrothal-isopropyl)、丙氧喹啉(proquinazid)、異丁乙氧喹啉(tebufloquin)、克枯爛 (tecloftalam)、咪唑嗪(triazoxide)、2-丁氧基-6-碘-3-丙基烯-4-酮、N-(環丙基甲氧基亞胺基-(6-二氟-甲氧基-2,3-二氟-苯基)-甲基)-2-苯基乙醯胺、N'-(4-(4-氯-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒、N'-(4-(4-氟-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒、N'-(2-甲基-5-三氟甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基甲脒、N'-(5-二氟甲基-2-甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基甲脒、2-{1-[2-(5-甲基-3-三氟甲基-吡唑-1-基)-乙醯基]-六氫吡啶-4-基}-噻唑-4-甲酸甲基-(1,2,3,4-四氫-萘-1-基)-醯胺、2-{1-[2-(5-甲基-3-三氟甲基-吡唑-1-基)-乙醯基]-六氫吡啶-4-基}-噻唑-4-甲酸甲基-(R)-1,2,3,4-四氫-萘-1-基-醯胺、1-[4-[4-[5-(2,6-二氟苯基)-4,5-二氫-3-異噁唑基]-2-噻唑基]-1-六氫吡啶基]-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮、甲氧基-乙酸6-第三-丁基-8-氟-2,3-二甲基-喹啉-4-基酯、N-甲基-2-{1-[(5-甲基-3-三氟甲基-1H-吡唑-1-基)-乙醯基]-六氫吡啶-4-基}-N-[(1R)-1,2,3,4-四氫萘-1-基]-4-噻唑甲醯胺、3-[5-(4-甲基苯基)-2,3-二甲基-異噁唑啶-3-基]-吡啶、3-[5-(4-氯-苯基)-2,3-二甲基-異噁唑啶-3-基]-吡啶(啶菌噁唑(pyrisoxazole))、N-(6-甲氧基-吡啶-3-基)環丙烷甲醯胺、5-氯-1-(4,6-二甲氧基-嘧啶-2-基)-2-甲基-1H-苯并咪唑、2-(4-氯-苯基)-N-[4-(3,4-二甲氧基-苯基)-異噁唑-5-基]-2-丙-2-炔基氧基-乙醯胺; L);適宜之殺昆蟲劑為- 有機(硫代)磷酸酯類:歐殺松(acephate)、唑啶磷(azamethiphos)、穀速松(azinphos-methyl)、陶斯松(chlorpyrifos)、甲基陶斯松(chlorpyrifos-methyl)、克芬松(chlorfenvinphos)、大利松(diazinon)、二氯松(dichlorvos)、雙特松(dicrotophos)、大滅松(dimethoate)、二硫松(disulfoton)、愛殺松(ethion)、撲滅松(fenitrothion)、芬殺松(fenthion)、加福松(isoxathion)、馬拉硫磷(malathion)、達馬松(methamidophos)、滅大松(methidathion)、甲基巴拉松(methyl-parathion)、美文松(mevinphos)、亞素靈(monocrotophos)、滅多松(oxydemeton-methyl)、雙氧磷(paraoxon)、巴拉松(parathion)、賽達松(phenthoate)、裕必松(phosalone)、益滅松(phosmet)、福賜米松(phosphamidon)、福瑞松(phorate)、辛硫磷(phoxim)、蟲蟎磷(pirimiphos-methyl)、布飛松(profenofos)、普硫松(prothiofos)、硫丙磷(sulprophos)、殺蟲畏(tetrachlorvinphos)、託福松(terbufos)、三落松(triazophos)、三氯松(trichlorfon);- 胺基甲酸酯類:棉鈴威(alanycarb)、得滅克(aldicarb)、免敵克(bendiocarb)、免扶克(benfuracarb)、加保利(carbaryl)、加保扶(carbofuran)、丁基加保扶(carbosulfan)、芬諾克(fenoxycarb)、呋線威(furathiocarb)、滅蟲威(methiocarb)、納乃得 (methomyl)、歐殺滅(oxamyl)、比加普(pirimicarb)、安丹(propoxur)、硫敵克(thiodicarb)、唑蚜威(triazamate);- 擬除蟲菊酯類:丙烯除蟲菊(allethrin)、畢芬寧(bifenthrin)、賽扶寧(cyfluthrin)、賽洛寧(cyhalothrin)、賽酚寧(cyphenothrin)、賽滅寧(cypermethrin)、α-賽滅寧、β-賽滅寧、ζ-賽滅寧、第滅寧(deltamethrin)、益化利(esfenvalerate)、依芬寧(ethofenprox)、芬普寧(fenpropathrin)、芬化利(fenvalerate)、依普寧(imiprothrin)、λ-賽洛寧、百滅寧(permethrin)、普亞列寧(prallethrin)、除蟲菊素(pyrethrin)I及II、苄呋菊酯(resmethrin)、矽護芬(silafluofen)、τ-福化利(tau-fluvalinate)、七氟菊酯(tefluthrin)、治滅寧(tetramethrin)、泰滅寧(tralomethrin)、拜富寧(transfluthrin)、丙氟菊酯(profluthrin)、四氟甲醚菊酯(dimefluthrin)、護賽寧(flucythirnate);- 昆蟲生長調節劑:a)甲殼質合成抑制劑:苯甲醯脲類:克福隆(chlorfluazuron)、賽滅淨(cyramazin)、二福隆(diflubenzuron)、氟環脲(flucycloxuron)、氟芬隆(flufenoxuron)、六伏隆(hexaflumuron)、祿芬隆(lufenuron)、諾伐隆(novaluron)、得福隆(teflubenzuron)、殺鈴脲(triflumuron);布芬淨(buprofezin)、戴芬蘭(diofenolan)、合賽多(hexythiazox)、依殺蟎(etoxazole)、克芬蟎 (clofentazine);b)蛻皮激素拮抗劑:合芬隆(halofenozide)、滅芬諾(methoxyfenozide)、得芬諾(tebufenozide)、印楝素(azadirachtin);c)類幼年素類:百利普芬(pyriproxyfen)、美賜平(methoprene)、芬諾克(fenoxycarb);d)脂質生物合成抑制劑:賜派芬(spirodiclofen)、螺甲蟎酯(spiromesifen)、螺蟲乙酯(spirotetramat);- 菸鹼受體激動劑/拮抗劑化合物:可尼丁(clothianidin)、達特南(dinotefuran)、益達胺(imidacloprid)、賽速安(thiamethoxam)、烯啶蟲胺(nitenpyram)、亞滅培(acetamiprid)、賽果培(thiacloprid)、1-(2-氯-噻唑-5-基甲基)-2-硝亞胺基-3,5-二甲基-[1,3,5]三唑烷;- GABA拮抗劑化合物:安殺番(endosulfan)、乙蟲清(ethiprole)、芬普尼(fipronil)、凡尼力普魯(vaniliprole)、比氟普魯(pyrafluprole)、比普魯(pyriprole)、5-胺基-1-(2,6-二氯-4-甲基-苯基)-4-胺亞磺醯基-1H-吡唑-3-甲硫醯胺;- 大環內酯殺昆蟲劑:阿巴汀(abamectin)、因滅汀(emamectin)、密滅汀(milbemectin)、萊培菌素(lepimectin)、賜諾殺(spinosad)、賜諾特(spinetoram);- 線粒體電子轉移抑制劑(METI)I殺蟎劑:芬殺蟎(fenazaquin)、畢達本(pyridaben)、得芬瑞(tebufenpyrad)、脫芬瑞(tolfenpyrad)、氟酚瑞姆(flufenerim); - METI II及III化合物:亞醌蟎(acequinocyl)、氟克瑞姆(fluacyprim)、愛美松(hydramethylnon);- 解偶聯劑:克凡派(chlorfenapyr);- 氧化磷酸化抑制劑:錫滿丹(cyhexatin)、汰芬隆(diafenthiuron)、芬佈賜(fenbutatin oxide)、毆蟎多(propargite);- 蛻皮干擾劑化合物:賽滅淨(cyromazine);- 混合功能氧化酶抑制劑:胡椒基丁醚;- 鈉通道阻斷劑:因得克(indoxacarb)、美氟綜(metaflumizone);- 其他:苯氯賽(benclothiaz)、必芬蟎(bifenazate)、培丹(cartap)、氟尼胺(flonicamid)、啶蟲丙醚(pyridalyl)、派滅淨(pymetrozine)、硫磺、硫賜安(thiocyclam)、氟蟲醯胺(flubendiamide)、氯蟲苯甲醯胺(chlorantraniliprole)、賽斯氟(cyazypyr)(HGW86)、賽諾若酚(cyenopyrafen)、吡氟硫磷(flupyrazofos)、賽芬蟎(cyflumetofen)、醯胺氟米特(amidoflumet)、依米賽氟(imicyafos)、雙三氟蟲脲(bistrifluron)及比氟喹腙(pyrifluquinazon)。 Suitable fungicides are: A) Respiratory Inhibitors - Inhibitors of Complex III at the Q o site: strobilurines, azoxystrobin, coumethoxystrobin, Coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin (fluoxastrobin), kresoxim-methy, metominostrobin, oressastrobin, picoxystrobin, baikemin (baikemin), pyrazolamide ( Pyrametostrobin), pyraoxystrobin, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-acrylic acid Ester and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylaminooxymethyl)-phenyl)-2-methoxyimino -N-methyl-acetamide; and pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone; - Q i locus Inhibitor of complex III Cyazofamid, amisulbrom, 2-methylpropionic acid [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-) Oxy-pyridine-2-carbonyl-amino]-6-methyl-4,9-di-oxy-1,5-dioxan-7-yl]-ester, 2-methylpropionic acid [(3S,6S,7R,8R)-8-benzyl-3-[[3-(ethyloxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6- Methyl-4,9-di-oxy-1,5-dioxan-7-yl], 2-methylpropionic acid [(3S,6S,7R,8R)-8-benzyl -3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl-amino]-6-methyl-4,9-di-oxy-1,5-di Oxacyclodec-7-yl]ester, 2-methylpropionic acid [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzo)diox Cyclopentene-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-di-oxy-1,5-dioxole Cycloalkyl-7-yl] ester; - inhibitor of complex II (eg, formazan): benodanil, bixafen, boscalid, carboxin , fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isopyrazol Amine (isopyrazam), mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, cyanofluoride Thifluzamide, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N- (2-(1,3,3-Trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide, N-[9- (Dichloromethylene)-1,2,3,4-tetrahydro-1,4-carbonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole- 4-methanamine; - other respiratory inhibitors (eg complex I, uncoupling agent): diflumetorim, (5,8-difluoroquinazolin-4-yl)-{2-[ 2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine; nitrophenyl derivative: binapacryl, large dislocation ( Dinobuton), dinocap, fluazinam; ferimzone; organometallic compounds: ametoctradin; and silthiofam; B) steroid biosynthesis Inhibitor (SBI fungicide) - C14 demethylase inhibitor (DMI fungicide): triazole: oxaconazole (azacona) Zole), bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, yip Epoxiconazole), fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, Metaconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, carbazole (simeconazole), tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole; imidazole: imazalil , pefurazoate, prochloraz, triflumizol; pyrimidine, pyridine and hexahydropyrazine: fenarimol, nuarimol, pyrifenox , triforine; - δ14-reductase inhibition Agents: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin ), piperalin, spiroxamine; - 3-ketoreductase inhibitor: fenhexamid; C) nucleic acid synthesis inhibitor - phenylguanamine or decylamine Base fungicides: benalaxyl, benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M Mefenoxam, ofurace, oxadixyl; - others: hymexazole, octhilinone, oxolinic acid, Bupirimate, 5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidine-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidine -4-amine; D) Inhibitors of cell division and cytoskeleton - Tubulin inhibitors, such as benzimidazole, thiophanate: benomyl, carbendazim, wheat ears Fuberidazole, thiabendazole, methyl Thiophanate-methyl; triazolopyrimidine: 5-chloro-7-(4-methylhexahydropyridin-1-yl)-6-(2,4,6-trifluorophenyl)-[1 , 2,4]triazolo[1,5-a]pyrimidine - other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide , zoxamide, metrafenone, pyrolifenone; E) amino acid and inhibitor of protein synthesis - methionine synthesis inhibitor (anilino-pyrimidine): match Cyprodinil, mepanipyrim, pyrimethanil; - protein synthesis inhibitors: blasticidin-S, kasugamycin, gibberellin hydrochloride Compound (kasugamycin hydrochloride-hydrate), mildiomycin, streptomycin, oxytetracyclin, polyoxine, and validamycin A; Signal transduction inhibitors - MAP / histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil ) Fludioxonil; - G protein inhibitor: quinoxyfen; G) lipid and membrane synthesis inhibitors - phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, white pine ( Pyrazophos), isoprothiolane;- lipid peroxidation peroxidation inhibitor: dicloran, quintozene, tecnazene, tolclofos- Methyl), biphenyl, chloroneb, etridiazole; phospholipid biosynthesis and cell wall deposition inhibitors: dimethomorph, flumorph, man Mandipropamid, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate and N-(1-(1-(4-cyano) -Phenyl) ethanesulfonyl)butan-2-yl)carbamic acid-(4-fluorophenyl) ester;- Compounds that affect cell membrane permeability and fatty acids: propamocarb, prok (propamocarb-hydrochlorid) H) Inhibitors with multiple sites - Inorganic active substances: -- Organochlorine compounds (eg o-phthalazinium) , sulfonamide, chloronitrile): anilazine, dichlofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pentachlorphenole and its salts, Phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide; Others: guanidine, dodine, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, Ignitine-tris (albesilate); I) cell wall synthesis inhibitors - inhibitors of glucan synthesis: vesinomycin, polyoxin B Melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, fenoxanil; J) plant defense inducer - S- Acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium; phosphonic acid :K) Unknown mode of action - chinomethionat, cyflufenamid, cymoxanil, debacarb, diclomezine, difenzoquat, grass Difenzoquat-methylsulfate, fenpyrazamine, flumetover, fluthiophene, flutianil, methasulfocarb, nitrapyrin, sputum Nitrothal-isopropyl, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3- Propyl Ace-4-one, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenylacetamidine Amine, N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methylformamidine, N '-(4-(4-Fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methylformamidine, N'-( 2-methyl-5-trifluoromethyl-4-(3-trimethyldecyl-propoxy)-phenyl)-N-ethyl-N-methylformamidine, N'-(5- Difluoromethyl-2-methyl-4-(3-trimethyldecyl-propoxy)-phenyl)-N-ethyl-N-methylformamidine, 2-{1-[2- (5-methyl-3-trifluoromethyl-pyrazol-1-yl)-ethinyl]-hexahydropyridin-4-yl}-thiazole-4-carboxylic acid methyl-(1,2,3, 4-tetrahydro-naphthalen-1-yl)-decylamine, 2-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-ethenyl]-hexa Hydropyridin-4-yl}-thiazole-4-carboxylic acid methyl-(R)-1,2,3,4-tetrahydro-naphthalen-1-yl-decylamine, 1-[4-[4-[5 -(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2-thiazolyl]-1-hexahydropyridyl]-2-[5-methyl-3 -(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinoline-4- Base ester, N-methyl-2-{1-[(5-methyl-3-trifluoro) -1H-pyrazol-1-yl)-ethenyl]-hexahydropyridin-4-yl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]- 4-thiazolylamide, 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazol-3-yl]-pyridine, 3-[5-(4-chloro -phenyl)-2,3-dimethyl-isoxazol-3-yl]-pyridine (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) ring Propane meglumine, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzimidazole, 2-(4-chloro-phenyl)- N-[4-(3,4-Dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide; L); suitable insecticide The agents are - organic (thio) phosphates: acephate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, gram Chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, pentoxon Fenitrothion), fenthion, isoxathion, malathion, methamidophos, methidathion, Methyl-parathion, mevinphos, monocrotophos, oxydemeton-methyl, paraoxon, parathion, phenthoate ), phosalone, phosmet, phosphamidon, phorate, phoxim, pirimiphos-methyl, profenofos , prothiofos, sulprophos, tetrachlorvinphos, terbufos, triazophos, trichlorfon;-carbamate: cotton boll Alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenno Fenoxycarb, furathiocarb, metiocarb, methodylyl, oxamyl, pirimicarb, propoxur, sulfur enemy Thiodicarb), triazamate;- pyrethroids: allethrin, bifenthrin, cyfluthrin ), cyhalothrin, cyphenothrin, cypermethrin, α-赛灭宁, β-赛灭宁, ζ-赛灭宁, 灭灭宁(deltamethrin),益化Esfenvalerate, ethofenprox, fenpropathrin, fenvalerate, imiprothrin, λ-cylonine, permethrin, prallethrin , pyrethrin (I and II), resmethrin, silafluofen, tau-fluvalinate, tefluthrin, and chlorpyrifos Tetramethrin), tralmethrin, transfluthrin, profluthrin, dimefluthrin, flucythirnate;- insect growth regulator: a) Chitin synthesis inhibitors: benzamidines: chlorfluazuron, cyramazin, diflubenzuron, flucycloxuron, flufenoxuron, hexaflu (hexaflumuron), lufenuron, novaluron, teflubenzuron, triflumuron; bufenfen (bu Profezin), diofenolan, hexythiazox, etoxazole, clofentazine; b) ecdysone antagonist: hafenofozide, methoxyfenozide , tebufenozide, azadirachtin; c) juveniles: pyriproxyfen, metoprene, fenoxycarb; d) lipid biosynthesis inhibition Agent: spirodiclofen, spiromesifen, spirotetramat; - nicotinic receptor agonist/antagonist compound: clothianidin, dinotefuran , imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1-(2-chloro-thiazol-5-yl 2-nitroimido-3,5-dimethyl-[1,3,5]triazolidine;- GABA antagonist compound: endosulfan, ethiprole, fen Fipronil, vaniliprole, pyrafluprole, pyriprol, 5-amino-1-(2,6-dichloro-4-methyl- Phenyl)-4-amine sulfinyl-1H- Pyrazole-3-methylthioguanamine; - macrolide insecticide: abamectin, emamectin, milbemectin, lepimectin, sino Spinosad, spinetoram;- mitochondrial electron transfer inhibitor (METI) I acaricide: fenazaquin, pyridaben, tebufenpyrad, defenfen (tolfenpyrad), flufenerim; - METI II and III compounds: acequinocyl, fluacyprim, hydramethylnon; - uncoupling agent: kefanpai Chlorfenapyr);- oxidative phosphorylation inhibitors: cyhexatin, diafenthiuron, fenbutatin oxide, propargite;- suede interfering compound: cyromazine )-- Mixed-function oxidase inhibitor: piperonyl butoxide; - sodium channel blocker: indoxacarb, metaflumizone; - others: benclothiaz, bifenfen ( Bifenazate), cartap, flonicamid, pyridalyl, pymetrozine, sulphur, Thiocyclam, flubendiamide, chlorantraniliprole, cyazypyr (HGW86), cyenopyrafen, flupyrazofos, Cyflumetofen, amidoflumet, imicyafos, bistrifluron and pyrifluquinazon.

囊封殺蟲劑包括上述殺蟲劑中之至少一者,其係一或多種殺真菌劑及/或一或多種殺昆蟲劑或一或多種殺真菌劑及/或一或多種殺昆蟲劑之混合物。 The encapsulated insecticide comprises at least one of the above-mentioned insecticides, which is one or more fungicides and/or one or more insecticides or one or more fungicides and/or one or more insecticides. mixture.

較佳殺昆蟲劑係擬除蟲菊酯類,較佳係丙烯除蟲菊、畢芬寧、賽扶寧、賽洛寧、賽滅寧、α-賽滅寧、β-賽滅寧、ξ-賽滅寧、第滅寧、益化利、芬普寧、芬化利、依普寧、 λ-賽洛寧、百滅寧、普亞列寧、除蟲菊素I及II、苄呋菊酯、τ-福化利、七氟菊酯、治滅寧、泰滅寧、拜富寧、丙氟菊酯、四氟甲醚菊酯及護賽寧;較佳擬除蟲菊酯係護賽寧。 Preferred insecticides are pyrethroids, preferably propylene pyrethrum, bifenin, savonon, cylonine, cyprofen, α-saiding, β-saiding, ξ-赛Ningning, Diming, Yihuali, Fenpanning, Fenhuali, Epnin, Λ-赛洛宁,百灭宁, 普亚列宁, pyrethrin I and II, fenfenyl ester, τ-fuhuali, heptamethrin, Zhiningning, Tainingning, Baifuling, Fenfluthrin, tetrafluthrin and chloramphenicol; preferably pyrethroids are protected.

同等較佳之殺昆蟲劑係菸鹼受體激動劑/拮抗劑化合物,其中益達胺、亞滅培、賽果培、烯啶蟲胺、可尼丁、賽速安及達特南較佳。 Equally preferred insecticides are nicotinic receptor agonist/antagonist compounds, of which edetamine, arbutin, celecoxib, nitenpyram, konidine, acesulfame and dadnam are preferred.

同等較佳之殺昆蟲劑係昆蟲生長調節劑,其中二福隆、得福隆、克福隆、氟芬隆、六伏隆、殺鈴脲、祿芬隆較佳,且得福隆及氟芬隆更佳。 Equally preferred insecticides are insect growth regulators, of which Fufulong, Defulong, Kefulong, Flufenoxalam, Hexafluronium, Chlortetracycline, Lufenron are preferred, and Fulong and Flufenide Long is better.

同等較佳之殺昆蟲劑係大環內酯殺昆蟲劑,其中萊培菌素、因滅汀苯甲酸鹽(emamectin benzoate)、阿巴汀、密滅汀較佳。 Equally preferred insecticides are macrolide insecticides, of which amphetamine, emamectin benzoate, abatatin, methiophene are preferred.

另一同樣較佳之殺昆蟲劑係克凡派。 Another equally preferred insecticide is kefanpai.

另一同樣較佳之殺昆蟲劑係美氟綜。 Another equally preferred insecticide is the Fluoride.

另一同樣較佳之殺昆蟲劑係芬普尼。 Another equally preferred insecticide is Fenpney.

另一同樣較佳之殺昆蟲劑係氯蟲醯胺(rynaxypyr)(氯斯胺普(chloranthraniliprole))。 Another equally preferred insecticide is rynaxypyr (chloranthraniliprole).

更佳之殺昆蟲劑係菸鹼受體激動劑/拮抗劑化合物,其中益達胺、亞滅培、賽果培、烯啶蟲胺、可尼丁、賽速安及達特南較佳。 More preferred insecticides are nicotinic receptor agonist/antagonist compounds, of which edetamine, arbutin, celecoxib, nitenpyram, konidine, acesulfame and dadnam are preferred.

同等更佳之殺昆蟲劑係昆蟲生長調節劑,其中二福隆、得福隆、克福隆、氟芬隆、六伏隆、殺鈴脲、祿芬隆較佳,且得福隆及氟芬隆更佳。 Equally better insecticides are insect growth regulators, of which Fufulong, Defulong, Kefulong, Flufenolone, Hexaproron, Chlortetracycline, Lufenron are preferred, and Fulong and Flufen Long is better.

同等更佳之殺昆蟲劑係大環內酯殺昆蟲劑,其中萊培菌素、因滅汀苯甲酸鹽、阿巴汀、密滅汀較佳。 An equally preferred insecticide is a macrolide insecticide, wherein the amphetamine, the indomethacin, the abatatin, and the methiophene are preferred.

另一同樣更佳之殺昆蟲劑係克凡派。 Another equally better insecticide is the Kaffi.

另一同樣更佳之殺昆蟲劑係美氟綜。 Another equally better insecticide is the Fluoride.

另一同樣更佳之殺昆蟲劑係芬普尼。 Another equally better insecticide is Fenpney.

另一同樣更佳之殺昆蟲劑係氯蟲醯胺(氯斯胺普)。 Another equally better insecticide is chlorantamine (closperm).

在一較佳實施例中,囊封殺蟲劑包括一或多種殺真菌劑。 In a preferred embodiment, the encapsulated pesticide comprises one or more fungicides.

較佳地,囊封殺蟲劑包括一或多種選自以下之殺蟲劑:嗜毬果傘素殺真菌劑之群,例如亞托敏、甲香菌酯、丁香菌酯、醚菌胺、烯肟菌酯、芬那敏史卓賓、芬咢史卓賓/氟菌蟎酯、氟嘧菌酯、克收欣、苯氧菌胺、肟醚菌胺、吡啶氧菌酯、百克敏、吡唑胺菌酯、唑菌酯、三氟敏、2-[2-(2,5-二甲基-苯氧基甲基)-苯基]-3-甲氧基-丙烯酸甲酯及2-(2-(3-(2,6-二氯苯基)-1-甲基-亞烯丙基胺基氧基甲基)-苯基)-2-甲氧基亞胺基-N-甲基-乙醯胺;選自以下之甲醯胺類殺真菌劑之群:麥鏽靈、必殺酚、白克列、萎鏽靈、甲呋醯胺、氟吡菌醯胺、福多寧、氟殺比得、福拉比、異吡唑醯胺、滅普寧、嘉保信、噴氟芬、吡噻菌胺、環丙吡菌胺、克枯爛、賽氟滅、N-(4'-三氟甲基硫代聯苯-2-基)-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(2-(1,3,3-三甲基-丁基)-苯基)-1,3-二甲基-5-氟-1H-吡唑-4-甲醯胺、N-[9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲醇萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺;咗類之群,例如氧環唑、比多 農、溴克座、環克座、待克利、達克利、達克利-M、依普座、芬克座、氟喹唑、護矽得、護汰芬、菲克利、易胺座、種菌唑、滅特座、邁克尼、氰霜唑、巴克素、平克座、普克利、丙硫菌唑、矽氟唑、得克利、四克利、三泰芬、三泰隆、滅菌唑、烯效唑;及各種活性物質之群,例如三賽唑、亞賜圃及加普胺。 Preferably, the encapsulated insecticide comprises one or more insecticides selected from the group consisting of echinocanthin fungicides, such as atoreno, mephate, syringic acid, norepine, Enoxacin, phenalamine, schizobin, flubenzolbine/fluoxetine, fluoxastrobin, kexinxin, phenoxystrobin, acesulfame, pyridoxine, dexamethasone, pyrazolamide Bacteriocin, pyraclostrobin, trifluoro-sensitive, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3-methoxy-methyl acrylate and 2-(2) -(3-(2,6-dichlorophenyl)-1-methyl-allylaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl- Acetamine; a group of methotrexate fungicides selected from the group consisting of: wheat rust, chlorfenapyr, leucoside, wiltonin, metoprofen, flupirtine, butonine, fluoride得得,福拉比, isopyrazolamide, chlorfenapyr, jiabaoxin, flufenac, pirfenium, ciprofloxacin, chlorhexidine, cyprofen, N-(4'-trifluoro Methylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3,3-trimethyl) -butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamidine , N-[9-(Dichloromethylene)-1,2,3,4-tetrahydro-1,4-carbonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl -1H-pyrazole-4-carboxamide; a group of terpenoids, such as oxycyclazole, more than Nong, Broken, Ring, Kleine, Dakli, Dakli-M, Epp, Fink, Froquinazole, Hydrazine, Difen, Fickley, Easy Amine, Oxazole , 灭座, 麦克尼, cyanosin, bucksin, pingke, pugli, propofol, flurazepam, derkeley, quaternary chlorpyrifos, triptyron, saponin, sterilized azole, uniconazole ; and a group of various active substances, such as triptothecin, acetonide and gupamine.

在一更佳實施例中,囊封殺蟲劑包括嗜毬果傘素殺真菌劑,其中亞托敏、甲香菌酯、丁香菌酯、醚菌胺、烯肟菌酯、芬那敏史卓賓、芬咢史卓賓/氟菌蟎酯、氟嘧菌酯、苯氧菌胺、肟醚菌胺、吡啶氧菌酯、百克敏、吡唑胺菌酯、唑菌酯、三氟敏較佳,百克敏、吡啶氧菌酯、氟嘧菌酯更佳且百克敏最佳。 In a more preferred embodiment, the encapsulated insecticide comprises a muscarinic fungicide, wherein the azotomin, the carbaryl ester, the syringic acid ester, the oxystrobin, the enestrobin, the phenamine宾, 芬 咢 卓 / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / Baikemin, pyridoxybacter, fluoxastrobin is better and the best is 100 grams.

在另一更佳實施例中,囊封殺蟲劑包括咗類殺真菌劑,其中氧環唑、比多農、溴克座、環克座、待克利、達克利、達克利-M、依普座、芬克座、氟喹唑、護矽得、護汰芬、菲克利、易胺座、種菌唑、滅特座、邁克尼、氰霜唑、巴克素、平克座、普克利、丙硫菌唑、矽氟唑、得克利、四克利、三泰芬、三泰隆、滅菌唑、烯效唑較佳,依普座、丙硫菌唑、待克利及普克利更佳,依普座、丙硫菌唑、待克利、普克利最佳且依普座至佳。 In another more preferred embodiment, the encapsulated insecticide comprises an anthraquinone fungicide wherein oxacyclazole, biconic, bluron, cyclist, holly, darke, darke-m, Puzuo, Fenke, fluoroquinazole, Hydrazine, Difen, Fickley, Easy Amine, Oxazole, Gator, McKee, Cyansulfazole, Bacchus, Pink, Puckley, Prothioconazole, flurazepam, derkele, tetraclimate, trimethoate, saponin, sterilized azole, and ureconazole are preferred, espresso, prothioconazole, sylvain and pugli are better, yup Block, prothioconazole, tonic, and Puckley are the best and the best.

在另一更佳實施例中,囊封殺蟲劑包括甲醯胺類殺真菌劑,其中必殺酚、氟殺比得、異吡唑醯胺、噴氟芬、吡噻菌胺、環丙吡菌胺、N-(4'-三氟甲基硫代聯苯-2-基)-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(2-(1,3,3-三甲基-丁 基)-苯基)-1,3-二甲基-5-氟-1H-吡唑-4-甲醯胺及N-[9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲醇萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺較佳,必殺酚、氟殺比得、異吡唑醯胺、噴氟芬、吡噻菌胺及環丙吡菌胺更佳且氟殺比得最佳。 In another more preferred embodiment, the encapsulated insecticide comprises a methotrexate fungicide, wherein the bactericidal phenol, the pirfenide, the isopyrazolamide, the flufenium, the pirfenium, the pirimipen Insectamine, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2 -(1,3,3-trimethyl-butyl (-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide and N-[9-(dichloromethylene)-1,2,3,4 -tetrahydro-1,4-methanol naphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide is preferred, chlorfenapyr, chlorpyrifos Isopyrazole, flufenac, penthiopyramine and ciprofloxacin are better and the ratio of fluorine is best.

在另一更佳實施例中,囊封殺蟲劑包括三賽唑、亞賜圃、芬諾尼、雙環維林、嘉賜黴素或加普胺,更佳係三賽唑或亞賜圃。 In another more preferred embodiment, the encapsulated insecticide comprises trimethoxazole, sulforaphane, fentonyl, bicyclovirin, carnitamicin or gupamine, more preferably trioxazole or samarium .

最佳囊封殺蟲劑係百克敏或氟殺比得,其中百克敏最佳。 The best encapsulated insecticide is Baikemin or Fluoride, and Baikemin is the best.

如上所述,亦可囊封殺蟲劑之混合物。較佳係百克敏及上述殺蟲劑中之至少一者之混合物。 As mentioned above, a mixture of insecticides can also be encapsulated. Preferably, it is a mixture of at least one of baikemin and the above-mentioned insecticide.

最佳混合物係表1所闡述之下列二元混合物。 The best mixture is the following binary mixture as set forth in Table 1.

表1之混合物通常以化合物I與組份II之以下重量比率包括活性物質:500:1至1:500、較佳地100:1至1:100、更佳地50:1至1:50、甚至更佳地20:1至1:20、尤佳地10:1至1:10、特定而言5:1至1:5。 The mixture of Table 1 generally comprises the active substance in a weight ratio of the following compound I to component II: from 500:1 to 1:500, preferably from 100:1 to 1:100, more preferably from 50:1 to 1:50. Even more preferably from 20:1 to 1:20, particularly preferably from 10:1 to 1:10, in particular from 5:1 to 1:5.

在一至佳實施例中,囊封殺蟲劑係百克敏、氟殺比得及混合物M-1、M-2、M3及M4,其中在此子組中,百克敏、氟殺比得及混合物M-1、M-2較佳,且百克敏、氟殺比得及混合物M-1更佳且百克敏最佳。 In a preferred embodiment, the encapsulated insecticide is a dexamethasone, a chlorpyrifos and a mixture of M-1, M-2, M3 and M4, wherein in this subgroup, a mixture of hexagram and fluororesin is obtained. M-1 and M-2 are preferred, and the keke-sensitive and fluoro-compounds are better than the mixture M-1 and the keke is the best.

囊封殺蟲劑佔調配物之1%至40%,、較佳地2%至25%、甚至更佳地8%至15%。若調配物中存在囊封活性成份及其他非囊封活性成份之混合物,則調配物含有1%至30%囊封活性成份及1%至30%非囊封活性成份、較佳地2%至15%囊封活性成份及2%至25%非囊封活性成份及甚至更佳地5%至15%囊封活性成份及5%至20%非囊封活性成份。 The encapsulated insecticide comprises from 1% to 40%, preferably from 2% to 25%, even more preferably from 8% to 15% of the formulation. If the formulation contains a mixture of the encapsulated active ingredient and other non-encapsulated active ingredients, the formulation contains from 1% to 30% encapsulated active ingredient and from 1% to 30% non-encapsulated active ingredient, preferably 2% to 15% encapsulates the active ingredient and 2% to 25% of the non-encapsulated active ingredient and even more preferably 5% to 15% of the encapsulated active ingredient and 5% to 20% of the non-encapsulated active ingredient.

膠囊之平均粒徑(藉助光散射獲得之z-平均值;較佳係D[4,3]平均值)為0.5 μm至50 μm、較佳地0.5 μm至10 μm、更佳地2 μm至10 μm且尤其5 μm至10 μm、至佳地6 μm至10 μm。 The average particle diameter of the capsule (z-average obtained by light scattering; preferably the average value of D[4,3]) is from 0.5 μm to 50 μm, preferably from 0.5 μm to 10 μm, more preferably from 2 μm to 10 μm and especially 5 μm to 10 μm, preferably 6 μm to 10 μm.

根據文獻中所記載之標準量測方法使用Malvern粒度儀3600E型或Malvern Mastersizer 2000來測定微膠囊分散液之粒徑。D[v,0.1]值意指10%之顆粒之粒徑(根據平均體積)達到此值。相應地,D[v,0.5]意指50%之顆粒之粒徑(根據平均體積)小於/等於此值,且D[v,0.9]意指90%之顆粒之粒徑(根據平均體積)小於/等於此值。範圍值(span value)係源自差D[v,0.9]-D[v,0.1]與D[v,0.5]之商。D[4.3]值係重量平均值。 The particle size of the microcapsule dispersion was determined according to the standard measurement method described in the literature using a Malvern Particle Size Analyzer Model 3600E or a Malvern Mastersizer 2000. The D[v, 0.1] value means that the particle size of 10% of the particles (according to the average volume) reaches this value. Accordingly, D[v, 0.5] means that the particle diameter of 50% of the particles (according to the average volume) is less than/equal to this value, and D[v, 0.9] means the particle diameter of 90% of the particles (according to the average volume) Less than / equal to this value. The span value is derived from the quotient of the difference D[v,0.9]-D[v,0.1] and D[v,0.5]. The D[4.3] value is the weight average.

膠囊核心之溶劑包括至少一種非極性溶劑(根據定義,此意指一或多種非極性溶劑)、一或多種非極性溶劑與極 性溶劑之混合物。極性溶劑係在25℃下於水中之溶解度為至少5重量%之溶劑。非極性溶劑係在25℃下於水中之溶解度小於5重量%之溶劑。 The solvent of the capsule core includes at least one non-polar solvent (by definition, this means one or more non-polar solvents), one or more non-polar solvents and polar a mixture of solvents. The polar solvent is a solvent having a solubility in water of at least 5% by weight at 25 °C. The non-polar solvent is a solvent having a solubility in water of less than 5% by weight at 25 °C.

適宜非極性溶劑係在室溫下於水中之溶解度<0.1%(w/w)且蒸餾範圍為130℃至300℃之C8-C11芳族石油衍生物(芳族烴)(以下列商標名稱購自ExxonMobil或BP:Solvesso® 100、Solvesso® 150、Solvesso® 200、30 Solvesso® 150ND、Solvesso® 200ND、Aromat ® 150、Aromat ® 200、Hydrosol® A 200、Hydrosol® A 230/270、Caromax® 20、Caromax® 28、Aromat® K 150、Aromat® K200、Shellsol ® A 150、Shellsol ® A 100、Fin® FAS-TX 150、Fin® FAS-TX 200);植物油,例如椰子油、棕櫚仁油、棕櫚油、大豆油、菜籽油、玉米油及上述油之甲基或乙基酯;烴,例如閃點介於40℃與250℃之間且蒸餾範圍介於150℃與450℃之間之芳族空乏烴(aromatic depleted)、直鏈石蠟烴、異石蠟烴、環石蠟烴;酯,例如類萜酯(例如乙酸異莰酯)、乙酸苄基酯、苯甲酸苄基酯、苯甲酸丁酯、乙酸2-乙氧基丙基酯、甲基丙二醇乙酸酯(methyl proxitol acetate);磷酸三丁基酯;及醯胺,例如N,N-二烷基烷基醯胺,較佳係脂肪酸二甲基醯胺,更佳係N,N-二甲基辛醯胺及/或N,N-二甲基癸醯胺(混合物係購自P.C.Hall公司之Hallcomide® M 8-10、購自Cognis之Agnique® KE3658、購自Clariant之Genagen® 4166)及n-辛基-2-吡咯啶酮(NOP)。 Suitable non-polar solvents are C 8 -C 11 aromatic petroleum derivatives (aromatic hydrocarbons) having a solubility in water <0.1% (w/w) at room temperature and a distillation range of 130 ° C to 300 ° C (with the following trademarks) The name is from ExxonMobil or BP: Solvesso® 100, Solvesso® 150, Solvesso® 200, 30 Solvesso® 150ND, Solvesso® 200ND, Aromat® 150, Aromat® 200, Hydrosol® A 200, Hydrosol® A 230/270, Caromax® 20, Caromax® 28, Aromat® K 150, Aromat® K200, Shellsol® A 150, Shellsol® A 100, Fin® FAS-TX 150, Fin® FAS-TX 200); vegetable oils such as coconut oil, palm kernel oil, Palm oil, soybean oil, rapeseed oil, corn oil and methyl or ethyl ester of the above oil; hydrocarbons such as flash point between 40 ° C and 250 ° C and distillation range between 150 ° C and 450 ° C Aromatic depleted hydrocarbons, linear paraffin hydrocarbons, isoparaffins, paraffin hydrocarbons; esters such as decyl esters (eg isodecyl acetate), benzyl acetate, benzyl benzoate, butyl benzoate Ester, 2-ethoxypropyl acetate, methyl proxitol acetate; tributyl phosphate And a guanamine such as N,N-dialkylalkylguanamine, preferably a fatty acid dimethyl decylamine, more preferably N,N-dimethyloctylamine and/or N,N-dimethyl The base amine (mixture is available from Hallcomide® M 8-10 from PCHall, Agnique® KE3658 from Cognis, Genagen® 4166 from Clariant) and n-octyl-2-pyrrolidone (NOP).

極性溶劑之實例係苯甲醚;亞碸,例如二甲基亞碸 (DMSO);及內酯,例如γ-丁內酯(GBLO);N-乙基-2-吡咯啶酮(NEP);及N-十二烷基吡咯啶酮;酮,例如2-庚酮、環己酮、苯乙酮及苯乙酮衍生物(例如4-甲氧基苯乙酮);及醇,例如環己醇、苄基醇、二丙酮醇(例如4-羥基-4-甲基-2-戊酮)、正辛醇、2-乙基己醇;及二酯,例如戊二酸二甲基酯及琥珀酸二甲基酯及己二酸二甲基酯之混合物(購自Rhodia之Rhodiasolv® RPDE)或戊二酸二異丁基酯及琥珀酸二異丁基酯及己二酸二異丁基酯之混合物;及二醇及衍生物,例如丙二醇單甲基醚乙酸酯、二丙二醇單甲基醚、丙二醇單苯基醚;及碳酸伸烷基酯,例如碳酸丙二酯、碳酸丁二酯;及吡咯啶酮、衍生物,例如N-乙基吡咯啶酮;及乳酸酯,例如乳酸正丙基酯、乳酸甲酯、乳酸乙酯、乳酸異丙基酯、乳酸丁酯,其係以商品名PURASOLV® NPL、PURASOLV® ML、PURASOLV® EL、PURASOLV® IPL、PURASOLV® BL購得,或選自至少兩種上述溶劑之混合物。 Examples of polar solvents are anisole; anthraquinones such as dimethyl hydrazine (DMSO); and lactones such as γ-butyrolactone (GBLO); N-ethyl-2-pyrrolidone (NEP); and N-dodecylpyrrolidone; ketones such as 2-heptanone , cyclohexanone, acetophenone and acetophenone derivatives (for example 4-methoxyacetophenone); and alcohols such as cyclohexanol, benzyl alcohol, diacetone alcohol (eg 4-hydroxy-4-methyl) Mixyl-2-pentanone), n-octanol, 2-ethylhexanol; and diesters such as dimethyl glutarate and dimethyl succinate and dimethyl adipate (purchased Rhodiasolv® RPDE from Rhodia or a mixture of diisobutyl glutarate and diisobutyl succinate and diisobutyl adipate; and diols and derivatives such as propylene glycol monomethyl ether Acid ester, dipropylene glycol monomethyl ether, propylene glycol monophenyl ether; and alkyl carbonate, such as propylene carbonate, butylene carbonate; and pyrrolidone, derivatives such as N-ethylpyrrolidone And lactate, such as n-propyl lactate, methyl lactate, ethyl lactate, isopropyl lactate, butyl lactate, under the trade names PURASOLV® NPL, PURASOLV® ML, PURASOLV® EL, PURASOLV® IPL, PURASOLV® BL purchase Or, selected from a mixture of at least two of the above solvents.

較佳地,膠囊核心之溶劑包括一或多種非極性溶劑。 Preferably, the solvent of the capsule core comprises one or more non-polar solvents.

較佳非極性溶劑係如下適宜非極性溶劑:在室溫下於水中之溶解度<0.1%(w/w)且蒸餾範圍為130℃至300℃之C8-C11芳族石油衍生物(芳族烴);植物油,例如椰子油、棕櫚仁油、棕櫚油、大豆油、菜籽油、玉米油及上述油之甲基或乙基酯;烴,例如閃點介於40℃與250℃之間且蒸餾範圍介於150℃與450℃之間之芳族空乏烴、直鏈石蠟烴、異石蠟烴、環石蠟烴;及醯胺,例如N,N-二烷基烷基醯胺, 較佳係脂肪酸二甲基醯胺,更佳係N,N-二甲基辛醯胺及/或N,N-二甲基癸醯胺。其他較佳非極性溶劑係類萜酸之酯,例如乙酸異莰酯。 Preferred non-polar solvents are as follows: a non-polar solvent: a C 8 -C 11 aromatic petroleum derivative having a solubility in water of <0.1% (w/w) at room temperature and a distillation range of 130 ° C to 300 ° C. a hydrocarbon, such as coconut oil, palm kernel oil, palm oil, soybean oil, rapeseed oil, corn oil, and a methyl or ethyl ester of the above oil; hydrocarbons such as flash points between 40 ° C and 250 ° C And an aromatic spent hydrocarbon, linear paraffin, isoparaffin, cycloparaffin; and amidoxime, such as N,N-dialkylalkylguanamine, between 150 ° C and 450 ° C; The preferred fatty acid dimethyl decylamine is more preferably N,N-dimethyloctylamine and/or N,N-dimethyl decylamine. Other preferred non-polar solvents are esters of phthalic acid, such as isodecyl acetate.

更佳非極性溶劑係在室溫下於水中之溶解度<0.1%(w/w)且蒸餾範圍為130℃至300℃之C8-C11芳族石油衍生物(芳族烴);烴,例如閃點介於40℃與250℃之間且蒸餾範圍介於150℃與450℃之間之芳族空乏烴、直鏈石蠟烴、異石蠟烴、環石蠟烴;及醯胺,例如N,N-二烷基烷基醯胺,較佳係脂肪酸二甲基醯胺,更佳係N,N-二甲基辛醯胺及/或N,N-二甲基癸醯胺。 More preferably, the non-polar solvent is a C 8 -C 11 aromatic petroleum derivative (aromatic hydrocarbon) having a solubility in water of <0.1% (w/w) at room temperature and a distillation range of from 130 ° C to 300 ° C; For example, aromatic spent hydrocarbons, linear paraffins, isoparaffins, cycloparaffins having a flash point between 40 ° C and 250 ° C and a distillation range between 150 ° C and 450 ° C; and guanamines such as N, The N-dialkylalkylguanamine is preferably a fatty acid dimethyl decylamine, more preferably N,N-dimethyloctylamine and/or N,N-dimethyl decylamine.

溶劑之所需量取決於所選溶劑之性質及意欲囊封於其中之一或多種活性成份之溶解度。舉例而言,適宜量為0,1% w/w至40% w/w、更佳5% w/w至25% w/w及甚至更佳8% w/w至15% w/w。溶劑之所有濃度皆係指最終調配物,亦即包含與其他結晶活性成份之混合物。 The amount of solvent required will depend on the nature of the solvent selected and the solubility of one or more of the active ingredients that are intended to be encapsulated. For example, a suitable amount is from 0,1% w/w to 40% w/w, more preferably from 5% w/w to 25% w/w and even more preferably from 8% w/w to 15% w/w. All concentrations of solvent refer to the final formulation, ie, a mixture with other crystalline active ingredients.

膠囊外殼重量相對於膠囊總重量之比率為1-25重量%、較佳地5-25重量%、更佳地5-20重量%、最佳地10-20重量%。 The ratio of the weight of the capsule shell to the total weight of the capsule is from 1 to 25% by weight, preferably from 5 to 25% by weight, more preferably from 5 to 20% by weight, most preferably from 10 to 20% by weight.

膠囊外殼重量相對於膠囊總重量之給定比率對應於壁厚度且壁厚度較佳為0.07 μm至0.5 μm、更佳地0.1 μm至0.4 μm及甚至更佳地0.13 μm至0.35 μm。 The given ratio of the weight of the capsule shell to the total weight of the capsule corresponds to the wall thickness and the wall thickness is preferably from 0.07 μm to 0.5 μm, more preferably from 0.1 μm to 0.4 μm and even more preferably from 0.13 μm to 0.35 μm.

膠囊外殼係基於包括呈聚合形式之多官能異氰酸酯及多胺之聚胺基甲酸酯。 The capsule shell is based on a polyurethane comprising a polyfunctional isocyanate and a polyamine in a polymerized form.

具有包括該等聚胺基甲酸酯之囊封材料的膠囊已眾所周 知且可以與先前技術類似之方式製得。其較佳藉由適宜聚合物壁形成材料之界面聚合製程來製備。界面聚合通常係在核心材料之水性油包水乳液或懸浮液中實施,該核心材料含有溶於其中之聚合物壁形成材料之至少一部分。在聚合期間,聚合物自核心材料分離至核心材料與水之間之邊界表面,藉此形成微膠囊壁。由此獲得微膠囊材料之水性懸浮液。用於製備含有殺蟲劑化合物之微膠囊的界面聚合製程之適宜方法已揭示於先前技術中,例如US 3,577,515、US 4,280,833、US 5,049,182、US 5,229,122、US 5,310,721、US 5,705,174、US 5,910,314、WO 95/13698、WO 00/10392、WO 01/68234、WO 03/099005、EP 619,073或EP 1,109,450,該等專利全部被引用。 Capsules having encapsulating materials comprising such polyurethanes have been well received It is known and can be made in a manner similar to the prior art. It is preferably prepared by an interfacial polymerization process suitable for polymer wall forming materials. Interfacial polymerization is typically carried out in an aqueous water-in-oil emulsion or suspension of a core material comprising at least a portion of the polymeric wall forming material dissolved therein. During polymerization, the polymer separates from the core material to the boundary surface between the core material and water, thereby forming a microcapsule wall. An aqueous suspension of the microcapsule material is thus obtained. Suitable methods for the preparation of interfacial polymerization processes for the preparation of microcapsules containing insecticidal compounds are disclosed in the prior art, for example, in US 3,577,515, US 4,280,833, US 5,049,182, US 5,229,122, US 5,310,721, US 5,705,174, US 5,910,314, WO 95/ 13698, WO 00/10392, WO 01/68234, WO 03/099005, EP 619,073 or EP 1,109,450, all of which are incorporated herein by reference.

用於本發明聚胺基甲酸酯膠囊之適宜壁形成材料包括呈聚合形式之多官能異氰酸酯(亦稱為聚異氰酸酯)及多胺。 Suitable wall forming materials for the polyurethane capsules of the present invention include polyfunctional isocyanates (also known as polyisocyanates) and polyamines in polymerized form.

亦已知異氰酸酯基團可與水反應生成胺基甲酸基團,從而可脫去二氧化碳以最終產生胺基團。 It is also known that isocyanate groups can react with water to form hydroxy formate groups so that carbon dioxide can be removed to ultimately produce amine groups.

因此,在另一實施例中,可藉由使多官能異氰酸酯與水反應來製備2-組份系統多官能異氰酸酯/多胺。 Thus, in another embodiment, a 2-component system polyfunctional isocyanate/polyamine can be prepared by reacting a polyfunctional isocyanate with water.

一般而言,聚胺基甲酸酯係藉由下述方式來形成:視情況在多官能醯氯存在下使具有至少兩個異氰酸酯基團之聚異氰酸酯與具有至少兩個一級胺基之多胺反應以形成聚脲壁材料。聚異氰酸酯可個別地或以兩種或更多者聚異氰酸酯之混合物形式使用。適用之聚異氰酸酯包含二異氰酸酯及三異氰酸酯,其中異氰酸酯基團與脂肪族或環脂族部分 (脂肪族異氰酸酯)或與芳族部分(芳族異氰酸酯)附接。 In general, polyurethanes are formed by the combination of polyisocyanates having at least two isocyanate groups and polyamines having at least two primary amine groups in the presence of polyfunctional ruthenium chloride, as appropriate. The reaction is to form a polyurea wall material. The polyisocyanates may be used singly or in the form of a mixture of two or more polyisocyanates. Suitable polyisocyanates include diisocyanates and triisocyanates in which isocyanate groups and aliphatic or cycloaliphatic moieties (Aliphatic isocyanate) or attached to an aromatic moiety (aromatic isocyanate).

適宜脂肪族二異氰酸酯之實例包含二異氰酸四亞甲基酯、二異氰酸五亞甲基酯及二異氰酸六亞甲基酯以及環脂族異氰酸酯,例如異佛爾酮二異氰酸酯、1,4-雙異氰酸基環己烷及雙-(4-異氰酸基環己基)甲烷。 Examples of suitable aliphatic diisocyanates include tetramethylene diisocyanate, pentamethylene diisocyanate and hexamethylene diisocyanate, and cycloaliphatic isocyanates such as isophorone diisocyanate. , 1,4-bisisocyanatocyclohexane and bis-(4-isocyanatocyclohexyl)methane.

適宜之芳族異氰酸酯包含甲苯二異氰酸酯(TDI:2,4-異構體與2,6-異構體之混合物)、二苯基甲烷-4,4'-二異氰酸酯(MDI)、多亞甲基多苯基異氰酸酯、2,4,4'-二苯基醚三異氰酸酯、二異氰酸3,3'-二甲基-4,4'-二苯基酯、二異氰3,3'-二甲氧基-4,4'-二苯基酸酯、二異氰酸1,5-伸萘基酯及4,4',4"-三苯基甲烷三異氰酸酯。亦適宜者為上述二異氰酸酯之較高碳數寡聚物,例如上述二異氰酸酯之異氰尿酸酯及二胺基甲酸酯(biurethe)及其與上述二異氰酸酯之混合物。 Suitable aromatic isocyanates comprise toluene diisocyanate (TDI: a mixture of 2,4-isomer and 2,6-isomer), diphenylmethane-4,4'-diisocyanate (MDI), poly-methylene Quitophenyl isocyanate, 2,4,4'-diphenyl ether triisocyanate, 3,3'-dimethyl-4,4'-diphenyl diisocyanate, diisocyanate 3,3' -dimethoxy-4,4'-diphenyl acid ester, 1,5-anthranyl diisocyanate and 4,4',4"-triphenylmethane triisocyanate. Also suitable for the above Higher carbon number oligomers of diisocyanates, such as the isocyanurates and biurethes of the above diisocyanates and mixtures thereof with the above diisocyanates.

在另一實施例中,聚異氰酸酯係寡聚異氰酸酯。該等寡聚異氰酸酯可包括呈寡聚形式的上述脂肪族二異氰酸酯及/或芳族異氰酸酯。寡聚異氰酸酯之平均官能度在2.0至4.0範圍內、較佳2.1至3.2、更佳2.3至3.0。通常,該等寡聚異氰酸酯之黏度(根據DIN 53018測定)在20 mPas至1000 mPas範圍內、更佳80 mPas至500 mPas且尤其150 mPas至320 mPas。該等寡聚異氰酸酯可(例如)以商品名Lupranat® M10、Lupranat® M20、Lupranat® M50、Lupranat® M70、Lupranat® M200、Lupranat® MM103或(脂肪族異氰酸酯)Basonat® A270或Basonat HI 100自BASF SE購得。 In another embodiment, the polyisocyanate is an oligomeric isocyanate. The oligomeric isocyanates may comprise the above aliphatic diisocyanates and/or aromatic isocyanates in oligomeric form. The average functionality of the oligomeric isocyanate is in the range of from 2.0 to 4.0, preferably from 2.1 to 3.2, more preferably from 2.3 to 3.0. Typically, the viscosity of the oligomeric isocyanates (determined according to DIN 53018) is in the range from 20 mPas to 1000 mPas, more preferably from 80 mPas to 500 mPas and especially from 150 mPas to 320 mPas. Such oligomeric isocyanates may, for example, be sold under the tradename Lupranat® M10, Lupranat® M20, Lupranat® M50, Lupranat® M70, Lupranat® M200, Lupranat® MM103 or (aliphatic isocyanate) Basonat® A270 or Basonat HI 100 from BASF SE purchased.

亦適宜者為二異氰酸酯與多元醇(例如乙二醇、甘油及三羥甲基丙烷)之加合物,該等加合物係藉由使每莫耳多元醇與對應於各別醇之羥基數目的莫耳數量的二異氰酸酯及該二異氰酸酯與上述二異氰酸酯之混合物加合來獲得。藉此,一些二異氰酸酯分子經由胺基甲酸酯基團連接至多元醇以形成高分子量聚異氰酸酯。尤其適宜之此類產物DESMODUR® L(Bayer公司,Pittsburgh)可藉由使3莫耳甲苯二異氰酸酯與1莫耳2-乙基甘油(1,1-雙羥甲基丙烷)反應來製備。其他適宜之產物係藉由使二異氰酸六亞甲基酯或異佛爾酮二異氰酸酯與乙二醇或甘油加合來獲得。 Also suitable are adducts of diisocyanates with polyols such as ethylene glycol, glycerol and trimethylolpropane, which are obtained by reacting each mole polyol with a hydroxyl group corresponding to the respective alcohol A number of moles of diisocyanate and a mixture of the diisocyanate and the above diisocyanate are added to obtain. Thereby, some diisocyanate molecules are linked to the polyol via a urethane group to form a high molecular weight polyisocyanate. Particularly suitable such products DESMODUR® L (Bayer, Pittsburgh) can be prepared by reacting 3 moles of toluene diisocyanate with 1 mole of 2-ethyl glycerol (1,1-bismethylolpropane). Other suitable products are obtained by adding hexamethylene diisocyanate or isophorone diisocyanate to ethylene glycol or glycerin.

較佳之聚異氰酸酯係異佛爾酮二異氰酸酯、二苯基甲烷-4,4'-二異氰酸酯、甲苯二異氰酸酯。在另一實施例中,較佳之聚異氰酸酯係寡聚異氰酸酯。 Preferred are polyisocyanate isophorone diisocyanate, diphenylmethane-4,4'-diisocyanate, toluene diisocyanate. In another embodiment, a polyisocyanate oligomeric isocyanate is preferred.

在本發明範圍內之適宜多胺應理解為通常意指彼等分子中含有兩個或更多個胺基之化合物,胺基可與脂肪族或芳族部分連接。 Suitable polyamines within the scope of the invention are understood to generally mean compounds in which two or more amine groups are present in the molecule, the amine group being attachable to the aliphatic or aromatic moiety.

適宜脂肪族多胺之實例係式H2N-(CH2-CH2-NH)n-H之聚乙烯亞胺,其中n係2至5之整數。該等聚乙烯亞胺之代表性實例係二伸乙基三胺、三伸乙基四胺、四伸乙基五胺及五伸乙基六胺。 An example of a suitable aliphatic polyamine is a polyethyleneimine of the formula H 2 N-(CH 2 -CH 2 -NH) n -H, wherein n is an integer from 2 to 5. Representative examples of such polyethyleneimines are di-ethyltriamine, tri-extension ethyltetramine, tetra-extended ethylpentamine, and penta-ethylhexamine.

適宜芳族多胺之實例係1,3,5-三胺基苯、2,4,6-三胺基甲苯、1,3,6-三胺基萘、2,4,4'-三胺基二苯基醚、3,4,5-三胺基-1,2,4-三咗及1,4,5,8-四胺基蒽醌。彼等不溶於或不能充分溶於水之多胺可以其鹽酸鹽形式使用。 Examples of suitable aromatic polyamines are 1,3,5-triaminobenzene, 2,4,6-triaminotoluene, 1,3,6-triaminonaphthalene, 2,4,4'-triamine Diphenyl ether, 3,4,5-triamino-1,2,4-trimethyl and 1,4,5,8-tetraaminopurine. The polyamines which are insoluble or insoluble in water can be used in the form of their hydrochlorides.

多胺(例如彼等上文所提及者)可個別地或以兩種或更多種多胺之混合物形式使用。 Polyamines (such as those mentioned above) may be used individually or as a mixture of two or more polyamines.

在本發明範圍內之適宜二胺應理解為通常意指彼等分子中含有兩個胺基之化合物,胺基可與脂肪族或芳族部分連接。 Suitable diamines within the scope of the invention are understood to mean generally the compounds containing two amine groups in the molecule, the amine groups being attachable to the aliphatic or aromatic moiety.

適宜脂肪族二胺之實例係式H2N-(CH2)n-NH2之α,ω-二胺,其中n為2至6之整數。 An example of a suitable aliphatic diamine is an alpha, omega-diamine of the formula H 2 N-(CH 2 ) n -NH 2 wherein n is an integer from 2 to 6.

適宜芳族二胺之實例係1,3-伸苯基二胺、2,4-及2,6-甲苯二胺、4,4'-二胺基二苯基甲烷、1,5-二胺基萘。彼等不溶於或不能充分溶於水之多胺可以其鹽酸鹽形式使用。 Examples of suitable aromatic diamines are 1,3-phenylenediamine, 2,4- and 2,6-toluenediamine, 4,4'-diaminodiphenylmethane, 1,5-diamine. Keina. The polyamines which are insoluble or insoluble in water can be used in the form of their hydrochlorides.

二胺(例如彼等上文所提及者)可個別地或以兩種或更多種二胺之混合物形式使用。 Diamines (such as those mentioned above) may be used individually or as a mixture of two or more diamines.

較佳二胺係如上文所定義之脂肪族二胺,其中式H2N-(CH2)n-NH2(其中n為2至6之整數)之α,ω-二胺較佳,乙二胺、伸丙基-1,3-二胺、四亞甲基二胺、五亞甲基二胺及六亞甲基二胺更佳,且六亞甲基二胺最佳。 Preferred diamines are aliphatic diamines as defined above, wherein the formula H 2 N-(CH 2 ) n —NH 2 (where n is an integer from 2 to 6) is preferably α,ω-diamine, B. The diamine, propyl-1,3-diamine, tetramethylenediamine, pentamethylenediamine and hexamethylenediamine are more preferred, and hexamethylenediamine is most preferred.

較佳胺係式H2N-(CH2-CH2-NH)n-H(其中n為2至5之整數)之脂肪族多胺,較佳係二伸乙基三胺、三伸乙基四胺、四伸乙基五胺及五伸乙基六胺,其中二伸乙基三胺最佳。 Preferred are aliphatic polyamines of the formula H 2 N-(CH 2 -CH 2 -NH) n -H (wherein n is an integer of from 2 to 5), preferably di-ethyltriamine, tris. The base tetraamine, the tetra-extension ethyl pentamine and the penta-ethylhexamine are the most preferred.

每一補充壁形成組份之相對量將隨多胺之等效重量而變化。一般而言,大約為化學計量的量較佳,而一種組份亦可過量使用,尤其係聚異氰酸酯過量。壁形成組份之總量大約對應於聚合壁形成材料之總量。 The relative amount of each complementary wall forming component will vary with the equivalent weight of the polyamine. In general, a stoichiometric amount is preferred, and a component may also be used in excess, especially in an excess of polyisocyanate. The total amount of wall forming components corresponds approximately to the total amount of polymeric wall forming material.

本發明微膠囊可另外包括表面活性劑,其溶於膠囊核心 之溶劑中。 The microcapsule of the present invention may additionally comprise a surfactant which is dissolved in the capsule core In the solvent.

表面活性劑重量相對於膠囊總重量之比率為1-60重量%、較佳地1-50重量%、更佳地15-40重量%、最佳地25-40重量%。 The ratio of the weight of the surfactant to the total weight of the capsule is from 1 to 60% by weight, preferably from 1 to 50% by weight, more preferably from 15 to 40% by weight, most preferably from 25 to 40% by weight.

適宜表面活性劑係非離子型表面活性劑。表面活性劑之實例列示於McCutcheon's,第1卷:Emulsifiers & Detergents,McCutcheon's Directories,Glen Rock,USA,2008(International Ed.或North American Ed.)中。 Suitable surfactants are nonionic surfactants. Examples of surfactants are listed in McCutcheon's, Vol. 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).

適宜非離子型表面活性劑之實例係烷氧基化物、烷氧基化N取代脂肪酸醯胺、氧化胺、酯、基於糖之表面活性劑、聚合物、嵌段聚合物、矽油及其混合物。烷氧基化物之實例係諸如以下已經烷氧基化具有1至50烷氧基當量之化合物:醇、烷基酚、胺、醯胺、芳基酚、脂肪酸或脂肪酸酯。可採用環氧乙烷及/或環氧丙烷來進行烷氧基化,較佳採用環氧乙烷。N-取代脂肪酸醯胺之實例係脂肪酸葡萄糖醯胺或脂肪酸烷醇醯胺。酯之實例係脂肪酸酯、甘油酯或甘油單酯。基於糖之表面活性劑之實例係山梨醇酐、乙氧基化山梨醇酐、蔗糖及葡萄糖酯或烷基聚葡萄糖苷。聚合物之實例係乙烯基吡咯啶酮、乙烯醇或乙酸乙烯基酯之均聚物或共聚物。矽油之實例係聚二甲基矽氧烷及烷氧基化聚二甲基矽氧烷衍生物,例如來自Evonik之Breakthru產品或來自O-Si Chemical之Silwet產品。嵌段聚合物之實例係A-B或A-B-A型(包括聚環氧乙烷及聚環氧丙烷之嵌段)或A-B-C型(包括烷醇、聚環氧乙烷及聚環氧丙烷)之嵌段 聚合物。 Examples of suitable nonionic surfactants are alkoxylates, alkoxylated N-substituted fatty acid guanamines, amine oxides, esters, sugar-based surfactants, polymers, block polymers, eucalyptus oils, and mixtures thereof. Examples of alkoxylates are, for example, compounds which have been alkoxylated to have an alkoxy equivalent of from 1 to 50: alcohols, alkylphenols, amines, decylamines, arylphenols, fatty acids or fatty acid esters. Alkoxylation can be carried out using ethylene oxide and/or propylene oxide, preferably ethylene oxide. Examples of N-substituted fatty acid guanamines are fatty acid glucosamine or fatty acid alkanolamines. Examples of esters are fatty acid esters, glycerides or monoglycerides. Examples of sugar-based surfactants are sorbitan, ethoxylated sorbitan, sucrose and glucose esters or alkyl polyglucosides. Examples of polymers are homopolymers or copolymers of vinylpyrrolidone, vinyl alcohol or vinyl acetate. Examples of eucalyptus oils are polydimethyl methoxy olefins and alkoxylated polydimethyl methoxy olefin derivatives such as the Breakthru product from Evonik or the Silwet product from O-Si Chemical. Examples of block polymers are block polymerizations of type AB or ABA (including blocks of polyethylene oxide and polypropylene oxide) or ABC types (including alkanols, polyethylene oxides, and polypropylene oxides). Things.

較佳非離子型表面活性劑係烷氧基化物及嵌段聚合物。 Preferred nonionic surfactants are alkoxylates and block polymers.

本發明微膠囊可進一步轉化成農業化學調配物。 The microcapsules of the invention can be further converted into an agrochemical formulation.

以已知方式如上所述藉助界面聚合(例如)藉由製備有機相及水相來製備微膠囊,其中有機相係存於適宜溶劑中之活性成份以及所需量之異氰酸酯及乳化劑之溶液。在5℃至30℃、較佳地15℃至25℃、最佳地18℃至25℃之溫度下使用高剪切混合設備(例如膠體磨機)將此溶液乳化成水相。端視在所選乳化劑及所選速率下之給定方案,膠體磨機之剪切力輸入將決定乳液液滴大小,該乳液液滴大小在窄範圍且與在完成膠囊形成製程之後接收之膠囊大小相同。考慮到特定方案,可藉由預設膠體磨機之旋轉速度(其等效於膠體磨機中之不同剪切力)來將乳液液滴大小分佈及由此膠囊大小分佈調節於某一範圍(其取決於所選方案)內。輕微攪拌所獲得乳液,同時緩慢添加稱取量之胺或胺溶液。完成添加之後,將混合物加熱至介於40-80℃之間之溫度保持2-24小時,然後完成固化反應。較佳溫度係50-70℃,甚至更佳地係55-65℃。最佳地,可使用紅外光譜確定反應之完成。在IR中,2300 cm-1至2250 cm-1之間之強帶表明仍存在未反應之異氰酸酯。隨著該帶完全消失,反應完成且將膠囊懸浮液冷卻至20-30℃。 The microcapsules are prepared in a known manner by interfacial polymerization, for example, by preparing an organic phase and an aqueous phase, wherein the organic phase is the active ingredient in a suitable solvent and a solution of the desired amount of isocyanate and emulsifier. The solution is emulsified into an aqueous phase using a high shear mixing apparatus (e.g., a colloid mill) at a temperature of 5 ° C to 30 ° C, preferably 15 ° C to 25 ° C, optimally 18 ° C to 25 ° C. Depending on the selected emulsifier and the given rate at the selected rate, the shear input of the colloid mill will determine the emulsion droplet size, which is in a narrow range and is received after the capsule formation process is completed. The capsules are the same size. In view of the specific solution, the emulsion droplet size distribution and thus the capsule size distribution can be adjusted to a certain range by presetting the rotational speed of the colloid mill, which is equivalent to the different shear forces in the colloid mill. It depends on the chosen program). The obtained emulsion was gently stirred while slowly adding a weighed amount of the amine or amine solution. After the addition is completed, the mixture is heated to a temperature between 40-80 ° C for 2-24 hours, and then the curing reaction is completed. The preferred temperature is 50-70 ° C, and even more preferably 55-65 ° C. Optimally, infrared spectroscopy can be used to determine the completion of the reaction. In IR, a strong band between 2300 cm-1 and 2250 cm-1 indicates the presence of unreacted isocyanate. As the band completely disappeared, the reaction was complete and the capsule suspension was cooled to 20-30 °C.

在一特定較佳實施例中,包括微膠囊之所得組合物包括以重量計,10-500 g/l、較佳地30-300 g/l、更佳地50-250g/l囊封殺蟲劑, 10 g-450 g/l、較佳地50 g-300 g/l、更佳地80 g-200 g/l有機溶劑,1-200 g/l表面活性劑(非離子型表面活性劑),35-80 g/l聚異氰酸酯及0,5-15 g/l多胺及水(補足至一升)。 In a particularly preferred embodiment, the resulting composition comprising microcapsules comprises from 10 to 500 g/l, preferably from 30 to 300 g/l, more preferably from 50 to 250 g/l of encapsulated insecticide, by weight. Agent, 10 g-450 g/l, preferably 50 g-300 g/l, more preferably 80 g-200 g/l organic solvent, 1-200 g/l surfactant (nonionic surfactant), 35-80 g/l polyisocyanate and 0,5-15 g/l polyamine and water (to one liter).

包封於膠囊中之有機溶劑、所溶解活性成份、可選表面活性劑及膠囊壁聚脲(藉由異氰酸酯及胺之反應形成)之重量總和相對於每升之總重量的比率有時稱為固體含量。此固體含量之範圍可為10% w/w至60% w/w、更佳地15% w/w至45% w/w、甚至更佳地20% w/w至35% w/w。 The ratio of the sum of the weight of the organic solvent encapsulated in the capsule, the dissolved active ingredient, the optional surfactant, and the capsule wall polyurea (formed by the reaction of the isocyanate and the amine) relative to the total weight per liter is sometimes referred to as Solid content. This solids content may range from 10% w/w to 60% w/w, more preferably from 15% w/w to 45% w/w, even more preferably from 20% w/w to 35% w/w.

可藉由將適宜助劑添加至所製得微膠囊及視情況另一殺蟲劑(如下所述)中以最終達成期望活性成份載量來製備農業化學調配物。最終調配物含有2-55% w/w、較佳地5-50% w/w、甚至更佳地15-50% w/w之膠囊。 Agrochemical formulations can be prepared by adding suitable auxiliaries to the resulting microcapsules and, optionally, another insecticide (described below) to ultimately achieve the desired active ingredient loading. The final formulation contains 2-55% w/w, preferably 5-50% w/w, even more preferably 15-50% w/w capsules.

適宜助劑之實例係溶劑、液體載劑、固體載劑或填充劑、表面活性劑(例如分散劑、乳化劑、潤濕劑、增溶劑、滲透增強劑、保護性膠體、黏著劑、佐劑)、增稠劑、保濕劑、驅蟲劑、引誘劑、增容劑、殺細菌劑、防凍劑、消泡劑、著色劑、增黏劑、緩衝劑及黏合劑。 Examples of suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants (eg dispersants, emulsifiers, wetting agents, solubilizers, penetration enhancers, protective colloids, adhesives, adjuvants) ), thickeners, humectants, insect repellents, attractants, compatibilizers, bactericides, antifreezes, defoamers, colorants, tackifiers, buffers and adhesives.

適宜表面活性劑係表面活性化合物(例如陰離子型、非離子型及兩性表面活性劑)、嵌段聚合物、聚電解質及其混合物。適宜表面活性劑可用作乳化劑、分散劑、增溶劑、潤濕劑、滲透增強劑、保護性膠體或佐劑。表面活性劑之實例列示於McCutcheon's,第1卷:Emulsifiers & Detergents,McCutcheon's Directories,Glen Rock,USA,2008(International Ed.或North American Ed.)中。 Suitable surfactants are surface active compounds (e.g., anionic, nonionic, and amphoteric surfactants), block polymers, polyelectrolytes, and mixtures thereof. Suitable surfactants can be used as emulsifiers, dispersants, solubilizers, wetting agents, penetration enhancers, protective colloids or adjuvants. Examples of surfactants are listed in McCutcheon's, Volume 1: Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).

用於最終膠囊懸浮液中之其他表面活性劑(例如分散劑、乳化劑、潤濕劑、增溶劑、滲透增強劑、保護性膠體、黏著劑)之量為5-25% w/w、較佳地5-20% w/w、更佳地7-15% w/w。 The amount of other surfactants (such as dispersants, emulsifiers, wetting agents, solubilizers, penetration enhancers, protective colloids, adhesives) used in the final capsule suspension is 5-25% w/w, Good land 5-20% w/w, more preferably 7-15% w/w.

適宜陰離子型表面活性劑係磺酸鹽、硫酸鹽、磷酸鹽、羧酸鹽之鹼金屬、鹼土金屬或銨鹽及其混合物。磺酸鹽之實例係烷基芳基磺酸鹽、二苯基磺酸鹽、α烯烴磺酸鹽、木質素磺酸鹽、脂肪酸及油之磺酸鹽、乙氧基化烷基酚之磺酸鹽、烷氧基化芳基酚之磺酸鹽、縮合萘之磺酸鹽、十二烷基-及十三烷基苯之磺酸鹽、萘及烷基萘之磺酸鹽、磺基琥珀酸鹽或磺基琥珀醯胺酸鹽。硫酸鹽之實例係脂肪酸及油、乙氧基化烷基酚、醇、乙氧基化醇或脂肪酸酯之硫酸鹽。磷酸鹽之實例係磷酸酯。羧酸鹽之實例係羧酸烷基鹽及羧基化醇或烷基酚乙氧基化物。 Suitable anionic surfactants are sulfonates, sulfates, phosphates, alkali metal, alkaline earth metal or ammonium salts of carboxylates and mixtures thereof. Examples of sulfonates are alkyl aryl sulfonates, diphenyl sulfonates, alpha olefin sulfonates, lignosulfonates, fatty acid and oil sulfonates, ethoxylated alkyl phenols. Sulfate, alkoxylated aryl sulfonate, condensed naphthalene sulfonate, dodecyl- and tridecylbenzene sulfonate, naphthalene and alkylnaphthalene sulfonate, sulfo group Succinate or sulfosuccinamide. Examples of sulphates are fatty acids and oils, ethoxylated alkyl phenols, alcohols, ethoxylated alcohols or sulfates of fatty acid esters. An example of a phosphate is a phosphate. Examples of carboxylates are alkyl carboxylates and carboxylated alcohols or alkylphenol ethoxylates.

適宜非離子型表面活性劑係烷氧基化物、N取代脂肪酸醯胺、氧化胺、酯、基於糖之表面活性劑、聚合表面活性劑及其混合物。烷氧基化物之實例係諸如以下已經烷氧基化具有1至50烷氧基當量之化合物:醇、烷基酚、胺、醯胺、芳基酚、脂肪酸或脂肪酸酯。可採用環氧乙烷及/或環氧丙烷及/或環氧丁烷來進行烷氧基化,較佳採用環氧乙烷。N-取代脂肪酸醯胺之實例亦係脂肪酸葡萄糖醯胺或脂肪酸烷醇醯胺。酯之實例係脂肪酸酯、甘油酯或甘油單 酯。基於糖之表面活性劑之實例係山梨醇酐、乙氧基化山梨醇酐、蔗糖及葡萄糖酯或烷基聚葡萄糖苷。聚合表面活性劑之實例係乙烯基吡咯啶酮、乙烯醇或乙酸乙烯基酯之均聚物或共聚物。 Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid guanamines, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are, for example, compounds which have been alkoxylated to have an alkoxy equivalent of from 1 to 50: alcohols, alkylphenols, amines, decylamines, arylphenols, fatty acids or fatty acid esters. Alkoxylation can be carried out using ethylene oxide and/or propylene oxide and/or butylene oxide, preferably ethylene oxide. Examples of N-substituted fatty acid decylamines are also fatty acid glucosides or fatty acid alkanolamines. Examples of esters are fatty acid esters, glycerides or glycerol ester. Examples of sugar-based surfactants are sorbitan, ethoxylated sorbitan, sucrose and glucose esters or alkyl polyglucosides. Examples of polymeric surfactants are homopolymers or copolymers of vinyl pyrrolidone, vinyl alcohol or vinyl acetate.

適宜陽離子型表面活性劑係四級表面活性劑(例如具有一個或兩個疏水性基團之四級銨合物)或長鏈一級胺之鹽。適宜兩性表面活性劑係烷基甜菜鹼及咪唑啉。嵌段聚合物之適宜實例係A-B或A-B-A型(包括聚環氧乙烷及聚環氧丙烷之嵌段)或A-B-C型(包括烷醇、聚環氧乙烷及聚環氧丙烷)之嵌段聚合物。適宜聚電解質係多元酸或多元鹼。多元酸之實例係聚丙烯酸之鹼鹽或多元酸梳形聚合物。多元鹼之實例係聚乙烯基胺或聚乙二胺。 Suitable cationic surfactants are fourth-grade surfactants (for example, quaternary ammonium compounds having one or two hydrophobic groups) or long-chain primary amine salts. Suitable amphoteric surfactants are alkyl betaines and imidazolines. Suitable examples of block polymers are blocks of type AB or ABA (including blocks of polyethylene oxide and polypropylene oxide) or blocks of ABC type (including alkanols, polyethylene oxides and polypropylene oxides). polymer. Suitable polyelectrolyte polybasic acids or polybasic bases. Examples of polybasic acids are polyacrylic acid base salts or polybasic acid comb polymers. Examples of polybasic bases are polyvinylamines or polyethylenediamines.

適宜佐劑係本身具有可忽略殺蟲活性或甚至沒有殺蟲活性且改良殺蟲劑對於目標之生物性能之化合物。實例係表面活性劑、礦物油或植物油及其他助劑。其他實例列示於Knowles,Adjuvants and additives,Agrow Reports DS256,T&F Informa UK,2006,第5章中。可用作佐劑之較佳表面活性劑係(例如)非離子型表面活性劑,例如烷氧基化物、N取代脂肪酸醯胺、酯、基於糖之表面活性劑、聚合表面活性劑及其混合物,烷氧基化物之實例係諸如以下已經烷氧基化具有1至50烷氧基當量之化合物:醇、烷基酚、胺、醯胺、芳基酚、脂肪酸或脂肪酸酯。可採用環氧乙烷及/或環氧丙烷及/或環氧丁烷來進行烷氧基化,較佳採用環氧乙烷及/或環氧丙烷。N-取代脂肪酸醯胺之實例係脂 肪酸葡萄糖醯胺或脂肪酸烷醇醯胺。酯之實例係脂肪酸酯、甘油酯或甘油單酯。基於糖之表面活性劑之實例係山梨醇酐、乙氧基化山梨醇酐、蔗糖及葡萄糖酯或烷基聚葡萄糖苷。聚合表面活性劑之實例係乙烯基吡咯啶酮、乙烯醇或乙酸乙烯基酯之均聚物或共聚物。若調配物中存在佐劑,則調配物中之佐劑量為3-40% w/w、較佳地5-20% w/w、甚至更佳地8-15% w/w。 Suitable adjuvant systems inherently have compounds which neglect pesticidal activity or even no insecticidal activity and which improve the biological properties of the insecticide for the target. Examples are surfactants, mineral or vegetable oils and other auxiliaries. Other examples are listed in Knowles, Adjuvants and others, Agrow Reports DS256, T&F Informa UK, 2006, Chapter 5. Preferred surfactants useful as adjuvants are, for example, nonionic surfactants such as alkoxylates, N-substituted fatty acid guanamines, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof Examples of alkoxylates are, for example, compounds which have been alkoxylated to have an alkoxy equivalent of from 1 to 50: alcohols, alkylphenols, amines, decylamines, arylphenols, fatty acids or fatty acid esters. The alkoxylation can be carried out using ethylene oxide and/or propylene oxide and/or butylene oxide, preferably ethylene oxide and/or propylene oxide. An example of an N-substituted fatty acid guanamine Fatty acid glucosamine or fatty acid alkanolamine. Examples of esters are fatty acid esters, glycerides or monoglycerides. Examples of sugar-based surfactants are sorbitan, ethoxylated sorbitan, sucrose and glucose esters or alkyl polyglucosides. Examples of polymeric surfactants are homopolymers or copolymers of vinyl pyrrolidone, vinyl alcohol or vinyl acetate. If an adjuvant is present in the formulation, the adjuvant will be in the formulation in an amount of from 3 to 40% w/w, preferably from 5 to 20% w/w, even more preferably from 8 to 15% w/w.

適宜殺細菌劑係溴硝丙二醇(bronopol)及異噻唑啉酮衍生物(例如烷基異噻唑啉酮及苯并異噻唑啉酮)。 Suitable bactericidal agents are bronopol and isothiazolinone derivatives (for example alkylisothiazolinones and benzisothiazolinones).

若調配物中存在殺細菌劑,則最終調配物中之殺生物劑之量之範圍為0.1-1%w/w、較佳地0.1-0.5% w/w、甚至更佳地0,1-0,3% w/w。 If a bactericide is present in the formulation, the amount of biocide in the final formulation ranges from 0.1 to 1% w/w, preferably from 0.1 to 0.5% w/w, and even more preferably from 0,1 0,3% w/w.

適宜增稠劑係多糖(例如黃原膠、羧甲基纖維素)、有機黏土(經有機改良或未經改良)、聚羧酸鹽及矽酸鹽。 Suitable thickeners are polysaccharides (eg xanthan gum, carboxymethylcellulose), organic clays (organic modified or unmodified), polycarboxylates and citrates.

若調配物中存在增稠劑,則最終調配物中之增稠劑之量之範圍為0,1-1,5% w/w、較佳地0,1-1,0% w/w、甚至更佳地0,2-0,5%。 If a thickener is present in the formulation, the amount of thickener in the final formulation will range from 0, 1-1, 5% w/w, preferably 0, 1-1, 0% w/w, Even better, 0, 2-0, 5%.

適宜防凍劑之係乙二醇、丙二醇、尿素及甘油。在較佳實施例中,調配物包括防凍劑。最終調配物中之防凍劑之量之範圍為2-15% w/w、較佳地4-10% w/w、甚至更佳地5-10%。 Suitable antifreeze agents are ethylene glycol, propylene glycol, urea and glycerin. In a preferred embodiment, the formulation includes an antifreeze. The amount of antifreeze in the final formulation ranges from 2 to 15% w/w, preferably from 4 to 10% w/w, and even more preferably from 5 to 10%.

適宜消泡劑係聚矽氧、長鏈醇、及脂肪酸鹽。 Suitable antifoaming agents are polyoxo, long chain alcohols, and fatty acid salts.

若調配物中存在消泡劑,則最終調配物中之消泡劑之量之範圍為0-5% w/w、較佳地0,1-1% w/w、甚至更佳地0,1- 0,5% w/w。 If an antifoaming agent is present in the formulation, the amount of defoaming agent in the final formulation ranges from 0 to 5% w/w, preferably from 0, 1-1% w/w, and even more preferably 0. 1- 0,5% w/w.

適宜緩衝劑係磷酸鹽緩衝劑、基於檸檬酸之緩衝劑、基於乙酸之緩衝劑及彼等熟習此項技術者已知之基於弱有機或無機酸之其他緩衝劑系統。請闡述擬用於CS「調配物」中之中和劑(緩衝劑)之重量比率。 Suitable buffering agents are phosphate buffers, citric acid based buffers, acetic acid based buffers and other buffer systems based on weak organic or inorganic acids known to those skilled in the art. Please describe the weight ratio of the neutralizer (buffer) to be used in the CS Formulation.

若調配物中存在緩衝劑,則最終調配物中之緩衝劑之量之範圍為0,1-10% w/w、較佳地0,1-3% w/w、甚至更佳地0,1-2%。 If a buffer is present in the formulation, the amount of buffer in the final formulation will range from 0, 1-10% w/w, preferably 0, 1-3% w/w, or even more preferably 0. 1-2%.

若最終調配物中存在其他助劑(例如保濕劑、驅蟲劑、引誘劑、增容劑、著色劑、增黏劑及黏合劑),則該等助劑之量為0.1% w/w至20% w/w。 If other additives (such as humectants, insect repellents, attractants, compatibilizers, colorants, tackifiers, and binders) are present in the final formulation, the amount of such adjuvants is 0.1% w/w to 20% w/w.

如上文所定義之調配物可視情況亦進一步包括其他非囊封殺蟲劑。 Formulations as defined above may also optionally include other non-encapsulated insecticides.

該其他殺蟲劑可選自上述殺蟲劑。該非囊封封之其他殺蟲劑可以溶解、懸浮及/或乳化形式存在。較佳地,非囊封之其他殺蟲劑係以分散形式、較佳地以懸浮於固體中之形式存在。在實踐中,該殺蟲劑可在後處理期間以研磨固體顆粒形式與適宜表面活性劑一起添加或以適宜調配物形式(例如以習用懸浮液濃縮物、可乳化有機溶液或溶解形式)添加。非囊封之其他殺蟲劑可包括殺真菌劑或殺昆蟲劑。 The other insecticide may be selected from the above insecticides. The non-encapsulated other insecticide may be present in dissolved, suspended and/or emulsified form. Preferably, the non-encapsulated other insecticide is present in a dispersed form, preferably in a form suspended in a solid. In practice, the insecticide may be added as a ground solid particle during post-treatment with a suitable surfactant or in a suitable formulation (for example in a conventional suspension concentrate, an emulsifiable organic solution or a dissolved form). Other non-encapsulated insecticides may include fungicides or insecticides.

較佳非囊封殺真菌劑係咗類殺真菌劑,其中氧環唑、比多農、溴克座、環克座、待克利、達克利、達克利-M、依普座、芬克座、氟喹唑、護矽得、護汰芬、菲克利、易胺 座、種菌唑、滅特座、邁克尼、氰霜唑、巴克素、平克座、普克利、丙硫菌唑、矽氟唑、得克利、四克利、三泰芬、三泰隆、滅菌唑、烯效唑較佳,依普座、丙硫菌唑、待克利及普克利更佳,依普座、丙硫菌唑、待克利、普克利最佳且依普座至佳。 Preferred non-encapsulated fungicides are steroidal fungicides, of which oxycyclazole, biconics, bromo, cycloure, holly, dyckley, dyckle-M, yup, fenque, Fluoroquinazole, Hydrazine, Difen, Fickley, Easy Amine Block, inocastazole, chlorpyrifos, miconi, cyanoxazole, bucksin, pingke, pugli, prothioconazole, guanidazole, dextran, quaternary chlorpyrifos, triptyron, taitailong, sterilized azole It is better to use uniconazole, Ipodil, prothioconazole, PK and Pkley, Epp, Prothioconazole, P. Klein, and Puckley are the best and Epson is the best.

在另一更佳實施例中,非囊封殺蟲劑包括甲醯胺類殺真菌劑,其中必殺酚、氟殺比得、異吡唑醯胺、噴氟芬、吡噻菌胺、環丙吡菌胺、N-(4'-三氟甲基硫代聯苯-2-基)-3-二氟甲基-1-甲基-1H-吡唑-4-甲醯胺、N-(2-(1,3,3-三甲基-丁基)-苯基)-1,3-二甲基-5-氟-1H-吡唑-4-甲醯胺及N-[9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲醇萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺較佳,必殺酚、氟殺比得、異吡唑醯胺、噴氟芬、吡噻菌胺及環丙吡菌胺更佳且氟殺比得最佳。 In another more preferred embodiment, the non-encapsulated insecticide comprises a methotrexate fungicide, wherein the bactericidal phenol, the chlorpyrifos, the isopyrazolamide, the flufenium, the pirfenium, the cyano Pyraclostrobin, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-( 2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide and N-[9-( Dichloromethylene)-1,2,3,4-tetrahydro-1,4-carbonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4 -Metformin is preferred, and the phenol, fluphene, isopyrazolamide, flufenac, pirimipenem and ciprofloxacin are preferred and the fluocyanide ratio is optimal.

在另一更佳實施例中,非囊封殺蟲劑包括三賽唑、亞賜圃、噻醯菌胺、異噻菌胺或加普胺,更佳地係三賽唑。 In another more preferred embodiment, the non-encapsulated insecticide comprises trimethoxazole, sulforaphane, thiabicide, isotianil or gupamine, more preferably trimethoprim.

在另一更佳實施例中,非囊封殺蟲劑包括嘉賜黴素、撲殺熱或雙氯氰菌胺。適宜組合之實例闡述於表2中,其中組合R-1至R-: In another more preferred embodiment, the non-encapsulated insecticide comprises carnitamicin, phlegm or dicyandiamide. Examples of suitable combinations are set forth in Table 2, where R-1 to R- are combined:

CS調配物通常包括20 g-400 g/l、較佳地30 g-250 g/l、更佳地40 g-200g/l及最佳地50 g-150 g/l之另一非囊封殺蟲劑。 The CS formulation typically comprises from 20 g to 400 g/l, preferably from 30 g to 250 g/l, more preferably from 40 g to 200 g/l, and most preferably from 50 g to 150 g/l. Insecticides.

本發明亦係關於增加稻田中之植物、特定而言稻米植物之健康之方法,其包括使用如上文所定義之調配物進行處 理。 The invention also relates to a method of increasing the health of a plant, in particular a rice plant, in a rice field, which comprises using a formulation as defined above Reason.

本發明進一步係關於防治稻田中之植物致病害蟲之方法,其包括使用如上文所定義之調配物進行處理。 The invention further relates to a method of controlling a phytopathogenic pest in a rice field, which comprises treating with a formulation as defined above.

端視膠囊核心中存在之活性物質亦或非囊封殺蟲劑之存在,術語「害蟲」係指植物致病真菌或植物致病昆蟲。 The term "pest" refers to a phytopathogenic fungus or a phytopathogenic insect by the presence of an active substance or a non-encapsulated insecticide present in the core of the capsule.

稻米中之植物致病真菌之實例係 Examples of phytopathogenic fungi in rice

稻米上之鏈格孢菌屬(Alternaria spp.)、雙極黴屬(Bipolaris)(例如胡麻葉斑病菌(Bipolaris oryzae))及稻米上之德氏黴屬(Drechslera species)、水稻尾孢黴(Cercospora oryzae)、旋孢腔菌(Cochliobolus miyabeanus)、新月彎孢菌(Curvularia lunata)、稻帚枝黴(Sarocladium oryzae)、水稻葉鞘腐敗病菌(S attenuatum)、稻葉黑粉菌(Entyloma oryzae)、鐮刀菌屬(Fusarium spp)(例如半裸鐮刀病菌(Fusarium semitectum))及/或串珠弗基克羅氏赤黴(moniliforme Gibberella fujikuroi)(惡苗)、穀粒染色複合物(各種病原體)及/或腐黴菌屬(Pythium ssp.)、長蠕孢屬(Helminthosporium.spp)(例如稻長蠕孢(Helminthosporium oryzae))、麯黴微結節菌(Microdochium oryzae)、稻瘟病菌(Pyricularia grisea)(同義詞:稻熱病菌(Pyricularia oryzae))、絲核菌屬(Rhizoctonia species)(例如立枯絲核菌(Rhizoctonia solani)(同義詞:稻米中之稻紋枯病菌(Pellicularia sasakii)))、稻紋炫f菌(Corticium sasakii)及稻綠核菌(Ustilaginoidea virens)。 Alternaria spp., Bipolaris (such as Bipolaris oryzae ), and Drechslera species on rice, Cercospora cerevisiae ( Cercospora oryzae ), Cochliobolus miyabeanus , Curvularia lunata , Sarocladium oryzae , S attenuatum , Entyloma oryzae , Fusarium spp (such as Fusarium semitectum ) and/or moniliforme Gibberella fujikuroi (malignant seedlings), grain dyeing complex (various pathogens) and/or rot spp, Helminthosporium (Helminthosporium .spp) (e.g. rice Helminthosporium (Helminthosporium oryzae)), Aspergillus fungus Microdochium (Microdochium oryzae), rice blast fungus (Pyricularia grisea) (synonyms (Pythium ssp.): rice thermal pathogen (Pyricularia oryzae)), Rhizoctonia (Rhizoctonia species) (e.g. Rhizoctonia solani (Rhizoctonia solani) (synonym: Rhizoctonia solani of rice grains (Pellicularia sasakii))) Rice sheath Hyun f bacteria (Corticium sasakii) and green rice solani (Ustilaginoidea virens).

稻米中之植物致病昆蟲之實例係稻米水象鼻蟲(稻水象 甲(Lissorhoptrus oryzaphilus))、稻米螟蟲(二化螟蟲(Chilo suppresalis))、稻米卷葉蟲、稻米葉泥蟲、稻米潛葉蟲(日本稻潛蠅(Agromyca oryzae))、葉蟬(由黑尾葉蟬(Nephotettix spp.);尤其係較小褐色葉蟬、綠色稻米葉蟬)、飛虱(飛虱科(Delphacidae);尤其係白背飛虱、褐色稻米飛虱)、臭蟲。 Examples of phytopathogenic insects in rice are rice water weevil ( Lissorhoptrus oryzaphilus ), rice aphid ( Chilo suppresalis ), rice leaf curler , rice leaf worm, rice latent Leaf worm (Agromyca oryzae), spider mites ( Nephotettix spp .; especially small brown leafhopper, green rice leafhopper), planthopper ( Delphacidae ) In particular, it is white-backed planthopper, brown rice planthopper, and bed bug.

在一較佳實施例中,防治稻田中之植物致病害蟲之方法包括使用如上文所定義之CS調配物進行處理,其中囊封殺蟲劑係百克敏且植物致病害蟲係稻瘟病菌(同義詞:稻熱病菌)及/或絲核菌屬(特定而言立枯絲核菌(同義詞:稻米中之稻紋枯病菌))。 In a preferred embodiment, the method of controlling a phytopathogenic pest in a rice field comprises treating with a CS formulation as defined above, wherein the encapsulated insecticide is a cytotoxic and phytopathogenic pest of Magnaporthe oryzae ( Synonym: rice fever pathogen and/or Rhizoctonia (specifically, Rhizoctonia solani (synonym: rice sheath blight in rice)).

在另一較佳實施例中,防治稻田中之植物致病害蟲之方法包括使用如上文所定義之CS調配物進行處理,其中囊封殺蟲劑係百克敏及氟殺比得且植物致病害蟲係稻瘟病菌(同義詞:稻熱病菌)及/或絲核菌屬(特定而言立枯絲核菌(同義詞:稻米中之稻紋枯病菌))。 In another preferred embodiment, the method of controlling a phytopathogenic pest in a rice field comprises treating with a CS formulation as defined above, wherein the encapsulated insecticide is a cytotoxic and chlorpyrifos and phytopathogenic The pest is a rice blast fungus (synonym: rice fever) and/or a genus Rhizoctonia (specifically, Rhizoctonia solani (synonym: rice sheath blight in rice)).

在另一較佳實施例中,防治稻田中之植物致病害蟲之方法包括使用如上文所定義之CS調配物進行處理,其中囊封殺蟲劑係百克敏,且非囊封殺蟲劑係氟殺比得,且植物致病害蟲係稻瘟病菌(同義詞:稻熱病菌)及/或絲核菌屬(特定而言立枯絲核菌(同義詞:稻米中之稻紋枯病菌))。 In another preferred embodiment, the method of controlling a phytopathogenic pest in a rice field comprises treating with a CS formulation as defined above, wherein the encapsulated insecticide is a kekemin and the non-encapsulated insecticide system Fluoride, and the plant pathogenic pest is Magnaporthe oryzae and/or Rhizoctonia (specifically, Rhizoctonia solani (synonym: Rhizoctonia solani) .

在另一較佳實施例中,防治稻田中之植物致病害蟲之方法包括使用如上文所定義之CS調配物進行處理,其中囊封殺蟲劑係百克敏,且非囊封殺蟲劑係三賽唑,且植物致病 害蟲係稻瘟病菌(同義詞:稻熱病菌)及/或絲核菌屬(特定而言立枯絲核菌(同義詞:稻米中之稻紋枯病菌))。 In another preferred embodiment, the method of controlling a phytopathogenic pest in a rice field comprises treating with a CS formulation as defined above, wherein the encapsulated insecticide is a kekemin and the non-encapsulated insecticide system Trimethoxazole, and plant pathogenicity The pest is a rice blast fungus (synonym: rice fever) and/or a genus Rhizoctonia (specifically, Rhizoctonia solani (synonym: rice sheath blight in rice)).

在上文提及之方法中,殺蟲劑之量通常介於10-500 g/ha之間。 In the above mentioned methods, the amount of the pesticide is usually between 10 and 500 g/ha.

舉例而言,對於百克敏而言,較佳比率為10-150 g/ha。 For example, for baikemin, a preferred ratio is 10-150 g/ha.

舉例而言,對於氟殺比得而言,較佳比率為10-120 g/ha For example, for fluridazole, a preferred ratio is 10-120 g/ha

藉由下列實例進一步闡釋本發明,但並不加以限制。 The invention is further illustrated by the following examples without limitation.

實例 Instance 實例1-微膠囊之製備 Example 1 - Preparation of microcapsules

Solvesso® 200:芳族烴溶劑,蒸餾範圍為238-278℃(購自Exxon) Solvesso® 200: aromatic hydrocarbon solvent with a distillation range of 238-278 ° C (purchased from Exxon)

Puccini® P 29:高度精緻之礦物油(購自Q8) Puccini® P 29: Highly refined mineral oil (purchased from Q8)

Plurafac® LF 1300:烷氧基化硬脂醇(購自BASF SE) Plurafac® LF 1300: alkoxylated stearyl alcohol (available from BASF SE)

Emulsogen® 3510:丁二醇、聚氧乙烯、聚氧丙烯嵌段共聚物(購自Clariant) Emulsogen® 3510: butanediol, polyoxyethylene, polyoxypropylene block copolymer (purchased from Clariant)

Tersperse® 2500:33 wt%甲基丙烯酸甲酯接枝聚合物(甲基丙烯酸甲酯、甲基丙烯酸及甲氧基PEG甲基丙烯酸酯之反應產物)、丙二醇及水(購自Huntsman) Tersperse® 2500: 33 wt% methyl methacrylate graft polymer (reaction product of methyl methacrylate, methacrylic acid and methoxy PEG methacrylate), propylene glycol and water (purchased from Huntsman)

Mowiol® 18-88:來自部分水解之聚乙酸乙烯基酯之聚乙烯醇(購自Kuraray) Mowiol® 18-88: Polyvinyl alcohol from partially hydrolyzed polyvinyl acetate (purchased from Kuraray)

Borresperse® Na:木質素磺酸鈉(購自Borregaard Lignotech) Borresperse® Na: sodium lignosulfonate (purchased from Borregaard Lignotech)

Lupranat® M 20 S:基於4,4'-二苯基甲烷二氰酸酯(MDI)且平均官能度為2,7之無溶劑聚異氰酸酯;NCO含量大約 為32 g/100 g(購自BASF Elastogran) Lupranat® M 20 S: Solvent-free polyisocyanate based on 4,4'-diphenylmethane dicyanate (MDI) with an average functionality of 2,7; NCO content approx. 32 g/100 g (available from BASF Elastogran)

Basonat® HI 100:六亞甲基-1,6-二異氰酸酯(購自BASF SE) Basonat® HI 100: hexamethylene-1,6-diisocyanate (available from BASF SE)

DETA:二伸乙基二胺(購自BASF SE) DETA: diethylene ethylamine (available from BASF SE)

HMDA:六亞甲基-1,6-二胺(購自BASF SE),10%水溶液 HMDA: hexamethylene-1,6-diamine (available from BASF SE), 10% aqueous solution

Atlox® 4912:使用聚乙二醇酯化之聚氫氧酸(購自Croda) Atlox® 4912: Polyethylene glycol esterified polyhydroxamic acid (available from Croda)

Acticide® MBS:用作殺生物劑之甲基異噻唑啉酮(MIT)及苯并異噻唑啉酮(BIT)之水溶液(購自Thor) Acticide® MBS: an aqueous solution of methylisothiazolinone (MIT) and benzisothiazolinone (BIT) used as a biocide (purchased from Thor)

Silicon SRE-PFL:用作消泡劑之存於二氧化矽顆粒上之 聚二甲基矽氧烷之乳液(購自Wacker) Silicon SRE-PFL: used as a defoamer on cerium oxide particles Polydimethyloxane emulsion (purchased from Wacker)

Plurafac LF 711:醇烷氧基化物(購自BASF SE) Plurafac LF 711: alcohol alkoxylate (available from BASF SE)

Plurafac LF 801:C8-C10醇烷氧基化物(購自BASF SE) Plurafac LF 801: C8-C10 alcohol alkoxylate (available from BASF SE)

Lutensol® ON 60:醇乙氧基化物(6 EO)(購自BASF SE) Lutensol® ON 60: Alcohol ethoxylate (6 EO) (available from BASF SE)

Genapol® C 100:椰子油乙氧基化物(10 EO)(購自Clariant) Genapol® C 100: Coconut Oil Ethoxylate (10 EO) (purchased from Clariant)

Lutensit® A-BO:二辛基磺基琥珀酸鈉存於水/丙二醇中之溶液(購自BASF SE) Lutensit® A-BO: a solution of sodium dioctylsulfosuccinate in water/propylene glycol (purchased from BASF SE)

Tween® 20:山梨醇酐單油酸酯乙氧基化物(購自Croda) Tween® 20: sorbitan monooleate ethoxylate (available from Croda)

Empilan® KR 6:C9/11醇乙氧基化物(6 EO)(購自Huntsman) Empilan® KR 6: C9/11 alcohol ethoxylate (6 EO) (purchased from Huntsman)

Synergen® GL 5:使用鄰苯二甲酸及椰子油脂肪酸酯化之聚甘油酯(購自Clariant) Synergen® GL 5: Polyglycerol esterified with phthalic acid and coconut oil fatty acid (purchased from Clariant)

Plurafac LF 900:醇烷氧基化物(購自BASF SE) Plurafac LF 900: alcohol alkoxylate (available from BASF SE)

Sipernat 22:非晶型沈澱二氧化矽(購自Evonik Industries) Sipernat 22: Amorphous precipitated cerium oxide (available from Evonik Industries)

使用如表I中所匯總之濃度[g/l;係指總體懸浮液之濃度]製備表1 A-D)及表2)中PU膠囊之懸浮液。 A suspension of PU capsules in Tables 1 A-D) and Table 2) was prepared using the concentrations [g/l; referred to as the concentration of the total suspension] as summarized in Table I.

對比實例[表2,1號]之組合物係WO10/105971之組合物。 The composition of the comparative example [Table 2, No. 1] is a composition of WO 10/105971.

藉由在環境溫度下將Borresperse Na溶於水中來製備水相。在單獨器皿中,製備存於溶劑中之百克敏溶液,視需要輕微加熱至最高60℃。在溶液變澄清之後,將其冷卻至20℃,且若膠囊核心含有其他表面活性劑,則添加該種其他表面活性劑且隨後溶解並最終添加一定量之異氰酸酯(如由配方所給出)。 The aqueous phase was prepared by dissolving Borresperse Na in water at ambient temperature. In a separate vessel, prepare a 100 grams of sensitive solution in a solvent and heat slightly to a maximum of 60 °C as needed. After the solution becomes clear, it is cooled to 20 ° C, and if the capsule core contains other surfactants, the other surfactant is added and subsequently dissolved and finally added with an amount of isocyanate (as given by the formulation).

然後藉由將有機溶液傾倒至水溶液中在適當大器皿中使用簡單翼式攪拌器來預乳化此溶液。在攪拌5-15秒之後,使整個內容物通過轉子-定子磨機在預設能量輸入位準(以%表示)為100%下(Cavitron CD 1000)進入反應器皿中,該反應器皿配備有緩慢攪動攪拌器、滴液漏斗及熱交換夾套。轉移完成後,以200 rpm啟動攪拌器且經15分鐘時段添加經稀釋胺溶液(通常為10% w/w)。 This solution is then pre-emulsified by pouring the organic solution into an aqueous solution using a simple wing agitator in a suitable large vessel. After stirring for 5-15 seconds, the entire contents were introduced into the reaction vessel through a rotor-stator mill at a preset energy input level (in %) of 100% (Cavitron CD 1000), which was equipped with a slow Stir the agitator, dropping funnel and heat exchange jacket. After the transfer was completed, the stirrer was started at 200 rpm and the diluted amine solution (usually 10% w/w) was added over a period of 15 minutes.

在完成胺添加後,開啟加熱且將囊封器皿內部之溫度增加至60℃保持4小時(端視方案及其中所使用異氰酸酯之量及類型)。最後,若在固化反應期間發生起泡,則添加一 部分消泡劑。 After the amine addition was completed, the heating was turned on and the temperature inside the encapsulating vessel was increased to 60 ° C for 4 hours (the end scheme and the amount and type of isocyanate used therein). Finally, if foaming occurs during the curing reaction, add one Part of the defoamer.

反應(其可藉由根據IR光譜中之異氰酸酯帶消失來監測)完成之後,冷卻混合物且藉由添加防凍劑、殺生物劑、殘餘量消泡劑、增黏劑、其他可選佐劑及水以調節靶定活性成份載量來進行後處理。 After completion of the reaction, which can be monitored by the disappearance of the isocyanate band in the IR spectrum, the mixture is cooled and added with antifreeze, biocide, residual defoamer, tackifier, other optional adjuvants and water. Post-treatment is carried out by adjusting the target active ingredient loading.

可將百克敏之此最終膠囊懸浮液進一步與其他活性成份(例如依普座)之懸浮液濃縮物混合,或可將表面活性劑/油混合物乳化成膠囊懸浮液或可納入其他表面活性劑。 The final capsule suspension of baikemin may be further mixed with a suspension concentrate of other active ingredients (e.g., Epp), or the surfactant/oil mixture may be emulsified into a capsule suspension or may be incorporated into other surfactants.

如下所述來測定非囊封百克敏(「游離百克敏」)之量: The amount of non-encapsulated 100-gram ("free 100 grams") was determined as follows:

在兩個步驟中稀釋調配物之較小試樣。首先,進行1:100稀釋且將試樣在22℃及不受驚擾下靜置2小時。接下來,以1:5000稀釋此試樣之等分試樣並在22℃下再次靜置2小時。 The smaller sample of the formulation was diluted in two steps. First, a 1:100 dilution was performed and the sample was allowed to stand at 22 ° C for 2 hours without being disturbed. Next, an aliquot of this sample was diluted 1:5000 and allowed to stand again at 22 ° C for 2 hours.

在第二靜置時間之後,以4000 rpm將試樣離心15分鐘且使澄清上清液之探針經受HPLC以分析游離百克敏含量。 After the second rest time, the sample was centrifuged at 4000 rpm for 15 minutes and the probe of the clarified supernatant was subjected to HPLC to analyze the free cytosentic content.

實例2 Example 2

將稻米以小地塊播種於田地中,每一地塊約1sqm並重複4次。當出現首次自然感染之跡象時,使用如表1/2中所指定之給定比率之調配物以約5001水/ha對其進行處理。 The rice was sown in the field in small plots, each plot was about 1 sqm and repeated 4 times. When the first signs of natural infection occurred, they were treated with a given ratio as specified in Table 1/2 at about 5001 water/ha.

另外,使用稻熱病菌孢子之接種物懸浮液對植物實施接種,該等接種物懸浮液係藉由在首次施加之後洗滌來自年久植物之感染葉材料產生。以7天之間隔施加3次。自首次相當應用之後第21天至最後一次施加之後第8天,以損害葉面積百分比之形式目測評價感染率且基於其來計算Abbott效能。 In addition, plants are inoculated with an inoculum suspension of M. thermophilus spores produced by washing infected leaf material from aged plants after the first application. Apply 3 times at 7 day intervals. From the 21st day after the first equivalent application to the 8th day after the last application, the infection rate was visually evaluated in the form of the percentage of damaged leaf area and the Abbott efficacy was calculated based thereon.

使用Abbot式之效能(E)計算如下:E=(1-α/β).100 α 對應於經處理植物之真菌感染(以%表示)且β 對應於未處理(對照)植物之真菌感染(以%表示) The Abbot-type performance (E) is calculated as follows: E = (1-α/β). 100 α corresponds to fungal infection of treated plants (expressed in %) and β corresponds to fungal infection of untreated (control) plants (expressed in %)

效能0意指經處理植物之感染程度對應於未處理控制植物之感染程度;效能100意指經處理植物未經感染。 Potency 0 means that the degree of infection of the treated plant corresponds to the degree of infection of the untreated control plant; efficacy 100 means that the treated plant is not infected.

其展示,儘管在稻田條件下在水中之釋放速率極其類似,但本發明調配物所展示之活性遠優於來自對比實例之先前技術調配物(表2,1號)。 It demonstrates that although the release rates in water under rice field conditions are very similar, the formulations exhibited by the present invention are far superior to the prior art formulations from the comparative examples (Table 2, No. 1).

Claims (15)

一種微膠囊,其中(v)該膠囊具有核心-外殼結構;且(vi)在25℃下至少80%之殺蟲劑溶於該核心中的有機溶劑中;且(vii)該膠囊外殼係基於包括呈聚合形式之多官能異氰酸酯及多胺之聚胺基甲酸酯;且(viii)膠囊外殼之重量相對於該膠囊之重量之比率為1重量%至20重量%。 a microcapsule wherein (v) the capsule has a core-shell structure; and (vi) at least 80% of the pesticide is dissolved in an organic solvent in the core at 25 ° C; and (vii) the capsule shell is based on A polyfunctional isocyanate and a polyamine polyurethane in a polymeric form are included; and (viii) the ratio of the weight of the capsule shell to the weight of the capsule is from 1% to 20% by weight. 如請求項1之微膠囊,其中該等膠囊之平均粒徑為0.5 μm至8 μm。 The microcapsule of claim 1, wherein the capsules have an average particle diameter of from 0.5 μm to 8 μm. 如請求項1或2之微膠囊,其中該溶劑包括至少一種非極性溶劑。 The microcapsule of claim 1 or 2, wherein the solvent comprises at least one non-polar solvent. 如請求項1或2之微膠囊,其另外在該核心中包括表面活性劑。 The microcapsule of claim 1 or 2 additionally comprising a surfactant in the core. 如請求項1或2之微膠囊,其中至少一種經囊封殺蟲劑係選自嗜毬果傘素(strobilurine)殺真菌劑或甲醯胺殺真菌劑之群。 The microcapsule of claim 1 or 2, wherein the at least one encapsulated insecticide is selected from the group consisting of a strobilurine fungicide or a methotrexate fungicide. 如請求項5之微膠囊,其中該嗜毬果傘素係百克敏(pyraclostrobin)。 The microcapsule of claim 5, wherein the tropin is a pyraclostrobin. 如請求項5之微膠囊,其中該經囊封甲醯胺殺真菌劑係氟殺比得(fluxapyroxad)。 The microcapsule of claim 5, wherein the encapsulated methotrexate fungicide is fluxapyroxad. 如請求項5之微膠囊,其中該經囊封殺真菌劑係氟殺比得及百克敏之混合物。 The microcapsule of claim 5, wherein the encapsulated fungicide is a mixture of hexamidine and hexagram. 一種調配物,其包括如請求項1至7中任一項之微膠囊及其他調配物助劑。 A formulation comprising the microcapsules of any of claims 1 to 7 and other formulation auxiliaries. 如請求項8之調配物,其進一步包括其他非囊封殺蟲劑。 The formulation of claim 8 further comprising other non-encapsulated insecticides. 如請求項10之調配物,其中該經囊封殺蟲劑係百克敏且該其他非囊封殺蟲劑係選自必殺酚(bixafen)、氟殺比得、異吡唑醯胺(isopyrazam)、噴氟芬(penflufen)、吡噻菌胺(penthiopyrad)、環丙吡菌胺(sedaxane)、三賽唑(tricyclazole)、亞賜圃(isoprothiolane)、加普胺(carpropamid)、依普座(epoxiconazole)、丙硫菌唑(prothioconazole)、待克利(difenoconazole)、普克利(propiconazole)、異噻菌胺(isotianil)、嘉賜黴素(kasugamycin)、加普胺、撲殺熱(probenazole)及雙氯氰菌胺(diclocymet)。 The formulation of claim 10, wherein the encapsulated insecticide is baikemin and the other non-encapsulated insecticide is selected from the group consisting of bixafen, pirimidol, isopyrazam , penflufen, penthiopyrad, sedaxane, tricyclazole, isoprothiolane, carpropamid, Epp Epoxiconazole, prothioconazole, difenoconazole, propiconazole, isotianil, kasugamycin, gupamine, probenazole, and bis Ciclocymet. 一種防治稻田中之植物致病害蟲之方法,其包括使用如請求項9或10之調配物進行處理。 A method of controlling a phytopathogenic pest in a rice field, which comprises treating with a formulation as claimed in claim 9 or 10. 一種增加稻田中之稻米植物之健康之方法,其包括使用如請求項9或10之調配物進行處理。 A method of increasing the health of a rice plant in a rice field, which comprises treating with a formulation as claimed in claim 9 or 10. 如請求項12之方法,其中該等害蟲係植物致病真菌。 The method of claim 12, wherein the pests are phytopathogenic fungi. 如請求項12之方法,其中該等害蟲係植物致病昆蟲。 The method of claim 12, wherein the pests are plant pathogenic insects.
TW101130035A 2011-08-19 2012-08-17 Formulations for paddy rice fields TW201315380A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11017812 2011-08-19

Publications (1)

Publication Number Publication Date
TW201315380A true TW201315380A (en) 2013-04-16

Family

ID=48802752

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101130035A TW201315380A (en) 2011-08-19 2012-08-17 Formulations for paddy rice fields

Country Status (1)

Country Link
TW (1) TW201315380A (en)

Similar Documents

Publication Publication Date Title
JP5992041B2 (en) Formulation for paddy field
AU2014329693B2 (en) Co-formulations of bifenthrin with encapsulated crop protection agents for use with liquid fertilizers
EP2706843B1 (en) Acrylate-acrylamide-amps terpolymer as dispersant for agrochemical formulations
CA2753984C (en) Method for treatment of crop with an encapsulated pesticide
EP2713720B1 (en) Copolymers of n-vinylcarboxamide and diallyldialkylammonium salt as dispersant for agrochemical formulations
TW201626890A (en) Fungicidal compositions
JP5965475B2 (en) Adjuvants containing dimethyl sulfoxide and phosphate esters
JP6370318B2 (en) Seed treatment formulation
CN106028820A (en) High-load pyrethroid encapsulated seed treatment formulations
JP2016513123A5 (en)
JP2020536883A (en) New pesticide pesticide composition
CN104202979A (en) Tank mix adjuvant comprising an alkyl polyglucoside and a base
CN104378989A (en) Liquid or particulate tank mix adjuvant comprising a base selected from a mixture of carbonate and hydrogencarbonate
TW201315380A (en) Formulations for paddy rice fields
EP3331362A1 (en) Microcapsule compositions comprising pyrimethanil
CN105472987B (en) Suspension-concentrates composition comprising isothiazoline insecticide and activated carbon
CA3176250A1 (en) Compositions and methods for controlling fungal diseases in plants